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ABSTRACT 
According to Article 12 of Regulation (EC) No 396/2005, the European Food Safety Authority (EFSA) has 
reviewed the Maximum Residue Levels (MRLs) currently established at European level for the pesticide active 
substance  thiabendazole.  In  order  to  assess  the  occurrence  of  thiabendazole  residues  in  plants,  processed 
commodities,  rotational  crops  and  livestock,  EFSA  considered  the  conclusions  derived  in the framework of 
Directive 91/414/EEC, the MRLs established by the Codex Alimentarius Commission as well as the import 
tolerances and European authorisations reported by Member States (incl. the supporting residues data). Based on 
the assessment of the available data, MRL proposals were derived and a consumer risk assessment was carried 
out.  Although  no  apparent  risk  to  consumers  was  identified,  some  information  required  by  the  regulatory 
framework was found to be missing. Hence, the consumer risk assessment is considered indicative only and all 
MRL proposals derived by EFSA still require further consideration by risk managers. 
© European Food Safety Authority, 2014 
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SUMMARY 
Thiabendazole was included in Annex I to Directive 91/414/EEC on 01 January 2002, which is before 
the  entry  into  force  of Regulation (EC) No 396/2005 on 02 September 2008. EFSA is therefore 
required to provide a reasoned opinion on the review of the existing MRLs for that active substance in 
compliance  with  Article  12(2)  of  the  aforementioned  regulation.  In  order  to  collect  the  relevant 
pesticide residues data, EFSA asked Spain, as the designated rapporteur Member State (RMS), to 
complete the Pesticide Residues Overview File (PROFile). The requested information was submitted 
to EFSA on 26 October 2009 and, after having considered several comments made by EFSA, the 
RMS provided on 07 May 2012 a revised PROFile. 
Based on the conclusions derived in the framework of Directive 91/414/EEC, the MRLs established 
by the Codex Alimentarius Commission and the additional information provided by the RMS, EFSA 
issued on 13 January 2014 a draft reasoned opinion that was circulated to Member States’ experts for 
consultation.  Comments  received  by  14  March  2014  were  considered  in  the  finalisation  of  this 
reasoned opinion. The following conclusions are derived. 
The toxicological profile of thiabendazole was evaluated in the framework of Directive 91/414/EEC, 
which  resulted  in  an  ADI  being  established  at  0.1  mg/kg  bw  per  d.  An  ARfD  was  not  deemed 
necessary. 
Primary crop metabolism of thiabendazole was investigated in four different crop groups following 
foliar  or  post-harvest  applications.  Results  indicate  that  following  post-harvest  treatment 
thiabendazole is the only relevant compound while following a pre-harvest application benzimidazole 
may be present at levels similar to the parent compound. This metabolite was not identified in the rat 
metabolism  and  further  information  on  the  toxicity  of  benzimidazole  is  required.  Moreover,  no 
justification was provided for not investigating the thiazolyl moiety of the compound. These data gaps 
will be further discussed under Regulation (EU) No 1141/2010 (in view of the possible renewal of the 
approval  of  this  active  substance).  Meanwhile,  the  relevant  residue  for  enforcement  and  risk 
assessment in all plant commodities following post-harvest treatments could be tentatively defined as 
thiabendazole only. It is also proposed to include benzimidazole in the residue definition for risk 
assessment of witloof which is the only crop reported in the framework of this review subject to a pre-
harvest treatment. Validated analytical methods for enforcement of the proposed residue definition are 
available with an LOQ of 0.01 mg/kg in high water content and acidic commodities. However, an 
analytical method with its ILV and with a confirmatory method fully validated for the determination 
of thiabendazole in high oil content commodities are still required. 
Regarding the magnitude of residues in primary crops, available residues trials data are sufficient to 
derive MRL proposals as well as risk assessment values for all commodities under evaluation, except 
for  bananas  where  the  available  data  were  insufficient  to  derive  MRLs  (see  also  Table  3-2). 
Considering that the residue definition in plants was derived on a tentative basis only, that a fully 
validated analytical method is still required for high oil content commodities, that further data are 
needed regarding the residue trials on apples and avocado, and that further storage stability data are 
still required, all MRL proposals should be considered on a tentative basis only. 
In  processed  commodities,  thiabendazole  residues  were  shown to be stable during pasteurisation, 
cooking, brewing and sterilisation. A detailed evaluation of this study is however still required in the 
framework of Regulation (EU) No 1141/2010. Meanwhile, the relevant residue for enforcement and 
risk assessment in processed commodities is expected to be the same as for primary crops. Magnitude 
of residues in processed commodities was also investigated and robust processing factors could only 
be derived for peeled citrus. With regard to the risk assessment, further processing studies are not 
required because they are not expected to affect the outcome of the risk assessment. However, if there Review of the existing MRLs for thiabendazole 
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would  be  the  intention  from  risk  managers  to  derive  more  processing  factors  for  enforcement 
purposes, additional processing studies might be required. 
Although  not required, the potential incorporation of soil residues into succeeding and rotational 
crops was investigated in turnip, lettuce and wheat. These studies showed a comparable metabolism 
as the one in primary crops. Based on the uses reported in the framework of this review, occurrence of 
residues through crop rotation is in any case not expected. 
Based on the uses reported by the RMS, significant intakes were calculated for ruminants, poultry and 
pigs. Metabolism in lactating ruminants and poultry was investigated and findings can be extrapolated 
to  pigs  as  well.  The  residue  for  enforcement  of  all  tissues  and  eggs  was  defined  as  the  sum  of 
thiabendazole and 5-hydroxythiabendazole, expressed as thiabendazole. For risk assessment purposes, 
it is proposed to also include benzimidazole in the residue definition. In milk, EFSA proposed to 
define  the  residue  for  both  enforcement  and  risk  assessment  as  the  sum  of  thiabendazole,  5-
hydroxythiabendazole and its sulphate conjugate, expressed as thiabendazole. However, these residue 
definitions are considered tentative  because further information on the toxicological properties of 
benzimidazole and further data on the fate of the thiazolyl moiety in ruminants and poultry are still 
required. These data gaps will be further discussed under Regulation (EU) No 1141/2010 (in view of 
the possible renewal of the approval of this active substance). Moreover, validated analytical methods 
for enforcement of these residue definitions are not available and are therefore required. The available 
livestock feeding studies on lactating cows and laying hens allowed EFSA to estimate the magnitude 
of  residues  in  ruminants,  poultry  and  pig  products  and  to  derive  MRLs  in  these  commodities. 
Considering however that the residue definition was derived on a tentative basis only and that further 
data on analytical methods, livestock feeding and storage stability are still required, these MRLs are 
tentative only.  
Chronic consumer exposure resulting from the  authorised  uses reported in the framework of this 
review  was  calculated  using  revision  2  of  the  EFSA  PRIMo.  For  bananas,  where  data  were 
insufficient to derive an MRL, EFSA considered the existing EU MRL for an indicative calculation. 
The  highest  chronic  exposure  represented  52.7  %  of  the  ADI  (Dutch  children).  Acute  exposure 
calculations  were  not  carried  out  because  an  ARfD  was  not  deemed  necessary  for  this  active 
substance. 
Apart from the MRLs evaluated in the framework of this review, internationally recommended CXLs 
have  also  been  established  for  thiabendazole.  Additional  calculations  of  the  consumer  exposure, 
considering these CXLs, were therefore carried out and the highest chronic exposure represented 
60.9 % of the ADI (Dutch children). 
MRLs  for  thiabendazole  in  products  of  animal  origin  are  also  established  in  the  framework  of 
Regulation (EU) N° 37/2010. These veterinary MRLs, resulting from the use of thiabendazole as a 
veterinary medicine in cattle and goat, are lower than or equal to the MRLs derived from the pesticide 
use for all commodities. Consequently, EFSA concludes that the veterinary MRLs are not expected to 
be of concern for European consumers. 
EFSA highlights that the consumer risk assessment is based on the toxicological reference values 
currently established by the European Commission which may be modified in the near future as a 
result  of  the peer review under Regulation (EU) No 1141/2010. If applicable, the consumer risk 
assessment for all crops reported in the framework of this review (including the CXLs) will need to be 
reconsidered. 
Based on the above assessment, EFSA does not recommend inclusion of this active substance in 
Annex IV to Regulation (EC) No 396/2005. MRL recommendations were derived in compliance with 
the decision tree reported in Appendix D (see summary table). None of the MRL values listed in the 
table  are  recommended  for  inclusion  in  Annex  II  to  the  Regulation  as  they  are  not  sufficiently Review of the existing MRLs for thiabendazole 
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supported by data (see summary table footnotes for details). In particular, certain tentative MRLs or 
existing EU MRLs still need to be confirmed by the following data: 
  a validated analytical method (with its ILV and a confirmatory method) for the determination 
of thiabendazole in high oil content commodities; 
  a validated analytical method (with its ILV and a confirmatory method) for the determination 
of the sum of thiabendazole and 5-hydroxythiabendazole in animal tissues and eggs; 
  a validated analytical method (with its ILV and a confirmatory method) for the determination 
of the sum of thiabendazole, 5-hydroxythiabendazole and its sulphate conjugates in milk; 
  further  data  on  the  toxicological  properties  of  benzimidazole  (to  be  addressed  under 
Regulation (EU) No 1141/2010); 
  further  data  on  the  fate  of  the  thiazolyl  moiety  in  plants,  ruminants  and  poultry  (to  be 
addressed under Regulation (EU) No 1141/2010); 
  additional  residues  trials  supporting with the authorised GAP  on apples and pears (to be 
addressed under Regulation (EU) No 1141/2010); 
  4 residue trials supporting the post-harvest GAP on bananas; 
  a detailed report on the supporting residue trials on avocado in order to identify independent 
trials and propose a correction factor to convert the data on stoneless fruit to whole fruit; 
  a study investigating the storage stability of thiabendazole (to be addressed under Regulation 
(EU) No 1141/2010); 
  a detailed evaluation of the hydrolysis study investigating nature of residues in processed 
commodities (to be addressed under Regulation (EU) No 1141/2010); 
  clarification on the characterisation of unidentified residues in ruminant and poultry liver (to 
be addressed under Regulation (EU) No 1141/2010); 
  a study investigating the storage stability of thiabendazole and 5-hydroxythiabendazole in fat 
(to be addressed under Regulation (EU) No 1141/2010); 
  a  detailed  evaluation  report  on  the  available  feeding  studies,  including  details  on  the 
analytical methods used and their capacity to analyse conjugates of 5-hydroxythiabendazole; 
  a livestock feeding study investigating all compounds included in the residue definition for 
risk assessment (depending on the outcome of other data gaps listed above). 
It is highlighted, however, that some of the MRLs derived result from a CXL, while other GAPs 
reported by the RMS were not fully supported by data. EFSA therefore identified the following data 
gap which is not expected to impact on the validity of the MRLs derived but which might have an 
impact on national authorisations: 
  clarifications regarding the equivalence of the different post-harvest treatments authorised on 
citrus fruits in Europe; 
If the above reported data gaps are not addressed in the future, Member States are recommended to 
withdraw or modify the relevant authorisations at national level. 
Minor deficiencies were also identified in the assessment but these deficiencies are not expected to 
impact either on the validity of the MRLs derived or on the national authorisations. The following 
data are therefore considered desirable but not essential: 
  4 residue trials on witloof including data on benzimidazole levels; 
  the storage conditions for all available residues trials; 
  the storage conditions of the samples from the livestock feeding studies. Review of the existing MRLs for thiabendazole 
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SUMMARY TABLE 
Code 
number 
Commodity  Existing 
EU MRL 
(mg/kg) 
Existing 
CXL 
(mg/kg) 
Outcome of the review 
MRL 
(mg/kg) 
Comment 
Enforcement residue definition: thiabendazole 
110000  Citrus fruit  5  7  7  Further consideration needed 
(a)   
130010  Apples  5  3  3  Further consideration needed 
(b) 
130020  Pears  5  3  3  Further consideration needed 
(b) 
130030  Quinces  0.05*  3  3  Further consideration needed 
(c)   
130040  Medlar  0.05*  3  3  Further consideration needed 
(c)  
130050  Loquat  0.05*  3  3  Further consideration needed 
(c)  
163010  Avocados  15  15  20  Further consideration needed 
(b) 
163020  Bananas  5  5  5  Further consideration needed 
(d) 
163030  Mangoes  5  5  20  Further consideration needed 
(b) 
163040  Papaya  10  10  10  Further consideration needed 
(b)  
211000  Potatoes  15  15  15  Further consideration needed 
(b)  
255000  Witloof  1  0.05*  0.05  Further consideration needed 
(b)  
280010  Cultivated fungi  10  60  60  Further consideration needed 
(c)  
-  Other products of plant 
origin 
App. C.1  App. C.2  -  Further consideration needed 
(e) 
Enforcement residue definition: sum of thiabendazole and 5-hydroxythiabendazole, expressed as 
thiabendazole 
1011010  Swine muscle  0.1  -  0.02  Further consideration needed 
(f) 
1011020  Swine fat (free of lean 
meat) 
0.1  -  0.03  Further consideration needed 
(f) 
1011030  Swine liver  0.1  -  0.15  Further consideration needed 
(f) 
1011040  Swine kidney  0.1  -  0.3  Further consideration needed 
(f) 
1012010  Bovine muscle  -  0.1  0.1  Further consideration needed 
(a)  
1012020  Bovine fat  -  0.1  0.1  Further consideration needed 
(a) 
1012030  Bovine liver  -  0.3  0.3  Further consideration needed 
(a)  
1012040  Bovine kidney  -  1  1  Further consideration needed 
(a)  
1013010  Sheep muscle  -  -  0.1  Further consideration needed 
(g) 
1013020  Sheep fat  -  -  0.1  Further consideration needed 
(g) 
1013030  Sheep liver  -  -  0.3  Further consideration needed 
(g) 
1013040  Sheep kidney  -  -  1  Further consideration needed 
(g) 
1014010  Goat muscle  -  -  0.1  Further consideration needed 
(g) 
1014020  Goat fat  -  -  0.1  Further consideration needed 
(g) 
1014030  Goat liver  -  -  0.3  Further consideration needed 
(g) 
1014040  Goat kidney  -  -  1  Further consideration needed 
(g) Review of the existing MRLs for thiabendazole 
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Code 
number 
Commodity  Existing 
EU MRL 
(mg/kg) 
Existing 
CXL 
(mg/kg) 
Outcome of the review 
MRL 
(mg/kg) 
Comment 
1016010  Poultry muscle  0.1  0.05  0.05  Further consideration needed 
(a)  
1016020  Poultry fat  0.1  0.05  0.05  Further consideration needed 
(a) 
1016030  Poultry liver  0.1  -  0.07  Further consideration needed 
(f) 
1030000  Birds' eggs  0.1*  0.1  0.1  Further consideration needed 
(a)  
-  Other products of animal 
origin (except milk) 
App. C.1  App. C.2  -  Further consideration needed 
(e) 
Enforcement residue definition: sum of thiabendazole, 5-hydroxythiabendazole and its sulphate conjugate, 
expressed as thiabendazole 
1020010  Cattle milk  -  0.2  0.2  Further consideration needed 
(a)  
1020020  Sheep milk  -  -  0.2  Further consideration needed 
(g) 
1020030  Goat milk  -  -  0.2  Further consideration needed 
(g) 
(*):  Indicates that the MRL is set at the limit of analytical quantification. 
(a):  MRL is derived from the existing CXL, which is not sufficiently supported by data but for which no risk to consumers 
is identified (assuming the existing residue definition); GAP evaluated at EU level, which is also not fully supported by 
data, would lead to a lower tentative MRL (combination E-V in Appendix D). 
(b):  Tentative MRL is derived from a GAP evaluated at EU level, which is not fully supported by data but for which no risk 
to consumers could be identified; existing CXL is covered by the tentative MRL (combination E-III in Appendix D). 
(c):  MRL is derived from the existing CXL, which is not sufficiently supported by data but for which no risk to consumers 
is  identified  (assuming  the  existing  residue  definition);  there  are  no  relevant  authorisations  or  import  tolerances 
reported at EU level (combination A-V in Appendix D). 
(d):  GAP evaluated at EU level is not supported by data but no risk to consumers could be identified for the existing EU 
MRL; existing CXL is covered by the existing EU MRL (combination C-III in Appendix D). 
(e):  There are no relevant authorisations or import tolerances reported at EU level; no CXL is available. Either the specific 
LOQ or the default MRL of 0.01 mg/kg may be considered (combination A-I in Appendix D). 
(f):  Tentative MRL is derived from a GAP evaluated at EU level, which is not fully supported by data but for which no risk 
to consumers could be identified (assuming the existing residue definition); no CXL is available (combination E-I in 
Appendix D). 
(g):  MRL is derived from the existing CXL for bovine, which is not sufficiently supported by data but which is considered 
applicable to other ruminants as well and for which no risk to consumers is identified (assuming the existing residue 
definition); GAP evaluated at EU level, which is also not fully supported by data, would lead to a lower tentative MRL 
(combination E-V in Appendix D). 
 Review of the existing MRLs for thiabendazole 
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BACKGROUND 
Regulation (EC) No 396/2005
4 establishes the rules governing the setting and the review of pesticide 
MRLs at European level. Article 12(2) of that regulation  stipulates that EFSA shall provide by 01 
September 2009 a reasoned opinion on the review of the existing MRLs for all active substances 
included in Annex I to  Directive 91/414/EEC
5 before  02 September 2008. As thiabendazole was 
included in Annex I to the above mentioned directive on  01 January 2002, EFSA initiated the review 
of all existing MRLs for that active substance and a  task with the reference number EFSA-Q-2008-
633 was included in the EFSA Register of Questions. 
According to the legal provisions, EFSA shall base its reasoned opinion in particular on the relevant 
assessment report prepared under Directive 91/414/EEC. It  should be noted, however, that in the 
framework of Directive 91/414/EEC only a few representative uses are evaluated, while MRLs set out 
in Regulation (EC) No 396/2005 should accommodate all uses authorised within the E U, and uses 
authorised in third countries that have a significant impact on international trade. The information 
included in the assessment report prepared under Directive 91/414/EEC is therefore insufficient for 
the assessment of all existing MRLs for a given active substance. 
In order to gain an overview of the pesticide residues data that have been considered for the setting of 
the existing MRLs, EFSA developed the Pesticide Residue Overview File (PROFile). The PROFile is 
an inventory of all pesticide residues data relevant to the risk assessment and MRL setting for a given 
active substance. This includes data on: 
  the nature and magnitude of residues in primary crops; 
  the nature and magnitude of residues in processed commodities;  
  the nature and magnitude of residues in rotational crops;  
  the nature and magnitude of residues in livestock commodities and;  
  the analytical methods for enforcement of the proposed MRLs. 
Spain, the designated rapporteur Member State (RMS) in the framework of Directive 91/414/EEC, 
was asked to complete the PROFile for thiabendazole. The requested information was submitted to 
EFSA on 26 October 2009 and subsequently checked for completeness. On 07 May 2012, after having 
clarified some issues with EFSA, the RMS provided a revised PROFile. 
A draft reasoned opinion was issued by EFSA on 13 January 2014 and submitted to Member States 
(MS) for commenting. All MS comments received by 14 March 2014 were considered by EFSA in the 
finalisation of the reasoned opinion. 
                                                       
4  Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue 
levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC. OJ L 
70, 16.3.2005, p. 1-16. 
5  Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market. OJ L 
230, 19.8.1991, p. 1-32.  Review of the existing MRLs for thiabendazole 
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TERMS OF REFERENCE 
According to Article 12 of Regulation (EC) No 396/2005, EFSA shall provide a reasoned opinion on: 
  the inclusion of the active substance in Annex IV to the Regulation, when appropriate; 
  the necessity of setting new MRLs for the active substance or deleting/modifying existing MRLs 
set out in Annex II or III of the Regulation; 
  the inclusion of the recommended MRLs in Annex II or III to the Regulation; 
  the setting of specific processing factors as referred to in Article 20(2) of the Regulation. 
 
THE ACTIVE SUBSTANCE AND ITS USE PATTERN 
Thiabendazole is the ISO common name for 2-(thiazol-4-yl)benzimidazole (IUPAC). 
N
H
N N
S
 
Thiabendazole belongs to the group of benzimidazole compounds which are used as fungicide, mainly 
for the post-harvest control of a wide range of diseases, including Aspergillus, Botrytis, Cladosporium 
and  Fusarium.  It  acts  by  compromising  the  cytoskeleton  through  a  selective  interaction  with  ß-
tubulin. Thiabendazole may also be used as a veterinary medicine on livestock for control of parasites 
such as roundworms, hookworms and other helminthes.  
Thiabendazole  was  evaluated  in  the  framework  of  Directive  91/414/EEC  with  Spain  being  the 
designated rapporteur Member State (RMS). The representative uses supported for the peer review 
process involved the post-harvest treatment of citrus fruit, pome fruit, banana, witloof and potato, the 
seed treatment of potato and the spraying and/or soil treatment on mushrooms. Following the peer 
review, a decision on inclusion of the active substance in Annex I to Directive 91/414/EEC was 
published by means of Commission Directive 2001/21/EC
6, which entered into force on 01 January 
2002. According to Regulation (EU) No 540/2011
7, thiabendazole is deemed to have been approved 
under Regulation (EC) No 1107/2009
8. This approval is restricted to uses as fungicide only. As EFSA 
was not yet involved in the peer review of  thiabendazole,  an  EFSA  conclusion  on this act ive 
substance is not available. It is highlighted that the overall pesticide risk assessment of thiabendazole 
is currently being peer reviewed under Regulation (EU) No 1141/2010
9 (in view of the possible 
renewal of the approval of this active substance).  This review process has however not yet been 
finalised. 
                                                       
6  Commission Directive 2001/21/EC of 5 March 2001 amending Annex I to Council Directive 91/414/EEC concerning the 
placing  of  plant  protection  products  on  the  market  to  include  amitrole,  diquat,  pyridate  and  thiabendazole  as  active 
substances. OJ L 69, 10.3.2001, p. 17–21. 
7  Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 
of the European Parliament and of the Council as regards the list of approved active substances. OJ L 153, 11.6.2011, p. 1-
186. 
8  Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing 
of  plant  protection  products  on  the  market  and  repealing  Council  Directives  79/117/EEC  and  91/414/EEC.  OJ  309, 
24.11.2009, p. 1-50. 
9  Commission Regulation (EU) No 1141/2010 of 7 December 2010 laying down the procedure for the renewal of the 
inclusion of a second group of active substances in Annex I to Council Directive 91/414/EEC and establishing the list of 
those substances. OJ L 322, 8.12.2010, p. 10–19. Review of the existing MRLs for thiabendazole 
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The  EU  MRLs  for  thiabendazole  are  established  in  Annexes  II  and  IIIB  of  Regulation  (EC) No 
396/2005. All existing EU MRLs, which are established for the parent compound only in products of 
plant origin and for the sum of thiabendazole and 5-hydroxythiabendazole expressed as thiabendazole 
in  products  of  animal  origin,  are  summarized  in  Appendix  C.1  to  this  document.  CXLs  for 
thiabendazole  were  also  established  by  the  Codex  Alimentarius  Commission  and  are  reported  in 
Appendix  C.2  to  this  reasoned  opinion.  These  CXLs  refer  to  the  same  definitions  proposed  by 
European Commission. Veterinary MRLs for thiabendazole were also laid down in Regulation (EU) 
No 37/2010
10 and are summarized in Appendix C.3 to this document. 
For the purpose of this MRL review, the critical uses of thiabendazole currently authorized within the 
EU as well as uses authorised in third countries that might have a significant impact on international 
trade, have been collected by the RMS and reported in the PROFile (see Appendix A). Thiabendazole 
is authorised  both within and outside Europe   for the  post-harvest treatment of several fruits and 
potatoes. In Europe, treatment of chicory roots prior to the forcing of witloof is also authorised. 
                                                       
10 Commission  Regulation  (EU)  No  37/2010  of  22  December  2009  on  pharmacologically  active  substances  and  their 
classification regarding maximum residue limits in foodstuffs of animal origin. OJ L 15, 20.1.2010, p. 1–72. Review of the existing MRLs for thiabendazole 
 
EFSA Journal 2014;12(7):3750  11 
ASSESSMENT 
EFSA bases its assessment on the PROFile submitted by the RMS, the Draft Assessment Report 
(DAR)  prepared  under  Council  Directive  91/414/EEC  (Spain,  1996),  the  Review  Report  on 
thiabendazole (EC, 2001) and the JMPR Evaluation reports (FAO, 1997, 2000, 2006) as well as the 
evaluation report submitted during the consultation of Member States (Spain, 2014). The assessment 
is performed in accordance with the legal provisions of the Uniform Principles for the Evaluation of 
the  Authorization  of  Plant  Protection  Products  adopted  by  Commission  Regulation  (EU) 
No 546/2011
11  and the currently applicable guidance documents relevant for the consumer risk 
assessment of pesticide residues (EC, 1996, 1997a-g, 2000, 2010a,b, 2011 and OECD, 2011). 
EFSA is aware that the overall pesticide risk assessme nt of thiabendazole is currently being peer 
reviewed under Regulation (EU) No 1141/2010 (in view of the possible renewal of the approval of 
this active substance). This review process has however not yet been finalised, hence the outcome 
thereof cannot be considered in the finalisation of this reasoned opinion. 
1.  Methods of analysis 
1.1.  Methods for enforcement of residues in food of plant origin 
During  the  peer  review  under  Directive  91/414/EEC,  an  analytical  method  using  HPLC  with 
fluorescence detection was evaluated for the determination of thiabendazole in plant matrices with an 
LOQ of 0.02 mg/kg in high water content commodities (bananas) and with an LOQ of 0.04 mg/kg in 
acidic  commodities  (citrus  fruits)  (Spain,  1996).  Nevertheless,  this  method  was  not  adequately 
validated because the number of samples at each fortification level was too low and no information 
was reported on the linearity, specificity or repeatability of the method. Furthermore, a confirmatory 
method and an ILV were not available and are required.  
The multi-residue QuEChERS method in combination with LC-MS/MS, as described by CEN (2008),  
is also reported for the analysis of parent thiabendazole with an LOQ of 0.01 mg/kg in high water 
content, high oil content and acidic commodities (see Table 1-1). Nevertheless, the validation data 
reported are too limited to conclude on the validity of this analytical method  in high oil content 
commodities. 
Table 1-1:  Recovery  data  for  the  analysis  of  thiabendazole  in  different  crop  groups  using  the 
QuEChERS method in combination with LC-MS/MS (EURL, 2013) 
Commodity group  Spiking levels 
(mg/kg) 
Recoveries  No of labs 
Mean (%)  RSD (%)  n 
Acidic  0.01  93  0.1  40  3 
0.1  88  0.1  89  3 
High water content  0.01  96  0.1  22  3 
0.1  84  0.2  27  3 
 
                                                       
11  Commission  Regulation  (EU)  No 546/2011  of  10 June  2011  implementing  Regulation  (EC)  No 1107/2009  of  the 
European  Parliament  and  of  the  Council  as  regards  uniform  principles  for  evaluation  and  authorisation  of  plant 
protection products. OJ L 155, 11.06.2011, p. 127-175. Review of the existing MRLs for thiabendazole 
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Hence it is concluded that thiabendazole can be enforced in food of plant origin with an LOQ of 
0.01 mg/kg  in  high  water  content  and  acidic  commodities.  However,  a  fully  validated  analytical 
method  (including  its  ILV  and  a  confirmatory  method)  is  still  required  for  the  determination  of 
thiabendazole in high oil content commodities. 
1.2.  Methods for enforcement of residues in food of animal origin 
During  the  peer  review  under  Directive  91/414/EEC,  an  analytical  method  using  HPLC  with 
fluorescence  detection  and  its  ILV  were evaluated for the determination of  thiabendazole and 5-
hydroxythiabendazole
12 in food of animal origin (Spain, 1996). Nevertheless, this analytical method 
was not adequately validated because the number of samples at each fortification level was to low and 
no information was reported on the linearity, specificity or repeatability of the method. Furthermore, a 
confirmatory  method  and  an  ILV  are  required  and  no  analytical  method  is  available  for  the 
determination of conjugates of 5-hydroxythiabendazole in food of animal origin. 
EURLs commented during the MS consultation that an analytical standard of the sulphate conjugate is 
not  commercially  available and the applicability of multi -residue methods would be  in any case 
questionable.  A  hydrolysis  step  for  its  transformation  to  5 -hydroxythiabendazole  is  therefore 
necessary. 
Meanwhile,  there is no evidence that the  sum of thiabendazole,  5-hydroxythiabendazole and its 
conjugates can  be enforced in food of animal origin. A n analytical method with its ILV and a 
confirmatory method fully validated for the determination of  proposed residue definitions (see also 
section 3) are still required. 
2.  Mammalian toxicology 
The toxicological assessment of thiabendazole was peer reviewed under Directive 91/414/EEC and 
toxicological  reference  values  were  established  by  the  European  Commission  (2001).  These 
toxicological reference values are summarized in Table 2-1. 
EFSA is aware that the toxicological assessment of thiabendazole is currently being peer reviewed 
under Regulation (EU) No 1141/2010 (in view of the possible renewal of the approval of this active 
substance) and that toxicological reference values of thiabendazole may therefore be modified in the 
near future. This review process has however not yet been finalised, hence the toxicological reference 
values as established by the European Commission are considered the most appropriate for the time 
being. 
Table 2-1:  Overview of the toxicological reference values 
  Source  Year  Value  Study relied upon  Safety 
factor 
Thiabendazole 
ADI  EC  2001  0.1 mg/kg bw per d  2-year rat  100 
ARfD  EC  2001  Not necessary 
 
                                                       
12 2-(1,3-thiazol-4-yl)-1H-benzimidazol-5-ol. See Appendix E. Review of the existing MRLs for thiabendazole 
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3.  Residues 
3.1.  Nature and magnitude of residues in plant 
3.1.1.  Primary crops 
3.1.1.1.  Nature of residues 
Metabolism of thiabendazole was investigated for foliar application on cereals (wheat), on pulses and 
oilseeds (soya bean) and on root and tuber vegetables (sugar beet) and for application by dipping on 
fruits and fruiting vegetables (orange) and on root and tuber vegetables (potato) using 
14C-phenyl 
labelled  thiabendazole  (Spain,  1996).  The  characteristics  of  these  studies  are  summarized  in 
Table 3-1. 
Table 3-1:  Summary of available metabolism studies in plants 
Group  Crop  Label 
position 
Application and sampling details 
Method,  
F or G 
(a) 
Rate  No  Sampling 
(DAT) 
Remarks 
Fruits and fruiting 
vegetable 
Orange 
14C-phenyl  Dipping, G  0.1 % a.s. 
in 1L 
cylinder 
-  0 to 28  Post-
harvest. 
Dipping for 
3 min. 
Root and tuber 
vegetables 
Potato  Dipping, G  50-500 mg 
a.s./L 
-  2, 10, 21, 
45, 75, 
120 
Post-
harvest. 
Dipping for 
5 min. 
Sugar beet  Foliar, F  0.40 kg 
a.s./ha 
5  0, 56, 90  Pre-harvest 
Pulses and 
oilseeds 
Soya bean  Foliar, F  0.34 kg 
a.s./ha 
2  0, 27, 78  Pre-harvest 
Cereals  Wheat  Foliar, F  0.80 kg 
a.s./ha 
1  0, 7, 37, 
63 
Pre-harvest 
(a):  Outdoor/field application (F) or glasshouse/protected/indoor application (G) 
 
Following foliar application, the highest TRR values were found in wheat forage (21.9 to 67.5 mg 
eq/kg) and straw (22.4 mg eq/kg), in soya bean foliage (14.3 to 25.5 mg eq/kg) and straw (10.2 mg 
eq/kg) and in sugar beet tops (10 to 24.7 mg eq/kg). TRR in edible parts were significantly lower, 
with 0.12 mg eq/kg in wheat grain, 0.88 mg eq/kg in soya bean seeds and 0.4 mg eq/kg in sugar beet 
roots.  
The main component of the residue in treated crops was parent thiabendazole (23 and 33 % TRR in 
wheat grain and straw respectively; 43 % TRR in soya bean seed; 26 and 27 % TRR in sugar beet root 
and tops respectively). Benzimidazole
13, in both free and sugar conjugate d form, was also observed 
(18 and 34 % TRR in wheat  grain and straw respectively; 11 and 14 % TRR in sugar beet root and 
tops respectively; 6 % TRR in soya bean seeds).  
                                                       
13 Benzimidazole. See Appendix E. Review of the existing MRLs for thiabendazole 
 
EFSA Journal 2014;12(7):3750  14 
Post-harvest  applications  of 
14C-thiabendazole  to  stored  potatoes  and  oranges  did  not  result  in 
detectable  metabolic  transformations.  The  major  residual  component  was  parent  thiabendazole; 
benzimidazole was not detected. Over 90 % of the TRR was located in the potato skins and orange 
peels and none was detected in the fleshy inner tissues. However, these studies were obtained from 
public literature and the underlying data could not be verified by EFSA. 
The available studies indicate that following post-harvest treatment thiabendazole is the only relevant 
compound while benzimidazole may be present at levels similar to the parent compound following a 
pre-harvest application; this is also confirmed by the rotational crop metabolism study reported in 
section 3.1.2. This metabolite was not identified in the rat metabolism and further information on the 
toxicity of benzimidazole is required. Moreover, no justification was provided for not investigating 
the thiazolyl moiety of the compound and the study summaries available so far do not comply with the 
current quality standards for reporting. It is noted however that these data gaps  will be discussed 
under Regulation (EU) No 1141/2010 (in view of the possible renewal of the approval of this active 
substance). 
Meanwhile, the residue for enforcement and risk assessment in all plant commodities following post-
harvest  treatments  is  tentatively  defined  as  thiabendazole  only.  Pending  the  assessment  of 
benzimidazole under Regulation (EU) No 1141/2010, it is also proposed to include benzimidazole in 
the residue definition for risk assessment of witloof which is the only crop reported in the framework 
of this review subject to a pre-harvest treatment. Validated analytical methods for enforcement of the 
proposed  residue  definition  are  available  (see  also  section  1.1)  except  for  high  oil  content 
commodities. Considering that the use of thiabendazole is also supported in avocados, an analytical 
method for enforcement of the proposed residue definition in high oil content is still required. 
3.1.1.2.  Magnitude of residues 
According  to  the  RMS,  the  active substance  thiabendazole is authorised both within and outside 
Europe for the post-harvest treatment of several fruits and potatoes. In Europe, treatment of chicory 
roots prior to the forcing of witloof is also authorised (see Appendix A). To assess the magnitude of 
thiabendazole residues resulting from these GAPs, EFSA considered all residue trials reported in the 
PROFile, including residue trials evaluated in the framework of the peer review (Spain, 1996) and 
additional  data  submitted  during  the  consultation  of  Member  States  (Spain,  2014).  All  available 
residue trials that, according to the RMS, comply with the authorised GAPs, are summarized in Table 
3-2. 
The number of residue trials and extrapolations were evaluated in  accordance with the European 
guidelines on comparability, extrapolation, group tolerances and data requirements for setting MRLs 
(EC, 2011). A sufficient number of trials complying with the GAP was reported by the RMS for all 
crops under assessment, except in the following cases: 
  Citrus fruits: post harvest treatment of citrus fruits is conducted either by drenching/dipping 
of  fruits  (oranges  and  mandarins)  or  by  on-line  water  or wax spraying (all citrus fruits). 
Residue trials on oranges and mandarins are only available to support the drenching/dipping 
GAP and it is not clear to EFSA if this GAP is equivalent to the GAP by on-line water or wax 
spraying. Therefore, MSs having authorised post-harvest treatments on citrus fruits are still 
required to clarify the equivalence of the application methods. Meanwhile, MRL and risk 
assessment values are derived for the whole group on the basis of the available data. 
  Apples and pears: All available residues trials were performed with a lower application rate 
than the one authorised. Although this application rate is within a 25 % percent deviation, all 
residue levels have been underestimated and the resulting MRL and risk assessment values 
may not adequately cover the authorised GAP on apples and pears. Additional residues trials Review of the existing MRLs for thiabendazole 
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compliant with the authorised GAP and confirming the findings of the available residues 
trials are therefore still required. It is noted that this data gap will also be discussed under 
Regulation (EU) No 1141/2010 (in view of the possible renewal of the approval of this active 
substance). 
  Bananas: no residue trials are available to support the post-harvest uses for this crop and 4 
residue  trials  on  bananas  complying with the post-harvest GAP are required. Meanwhile, 
neither MRLs nor risk assessment values can be derived. 
  Avocados and mangoes: sufficient residue trials are available but residues were determined 
on stoneless fruits, whereas the MRL on avocado and mango should refer to whole fruits. The 
MRL and risk assessment derived from this data are therefore likely to be overestimated. 
Moreover, it is not clear to EFSA whether or not replicates of a same trial were reported as 
individual values. Although tentative MRL and risk assessment values can be derived from 
the  available  data,  MSs  having  granted  this  import  tolerance  are  requested  to  provide  a 
detailed Evaluation Report including the supporting residue trials on avocado and to propose 
a correction factor for conversion of the data on stoneless fruit to whole fruit. 
  Witloof: the available residues trials did not investigate presence of benzimidazole. However, 
based on the available metabolism studies and rotational crop studies, it is expected that 
benzimidazole will be present at a level similar to the parent compound. A conversion factor 
of 2 for enforcement to risk assessment is therefore expected to be sufficiently conservative. 
Further  residues  trials  investigating  levels  of  benzimidazole  levels  would  normally  be 
required to confirm this conversion factor, but considering the low contribution of witloof to 
the exposure of consumers, these trials are only considered desirable (minor deficiency). 
The potential degradation of residues during storage of the residue trials samples was also assessed by 
the  JMPR  in  apples,  apple  juice,  apple  pomace,  bananas,  citrus  fruits,  mushrooms,  potatoes  and 
wheat. Overall, storage stability of thiabendazole was demonstrated for a period of 27 months at 
-20°C in commodities with high water content (potato), 9 months at -20°C in commodities with high 
acid content (citrus) and high oil content (citrus oil) and 23 months at -20°C in dry commodities 
(wheat grain) (FAO, 1997). The storage conditions were not reported for all available residues trials 
and considering that storage stability in high acid content commodities was only demonstrated for 9 
months, this information is in principle required in order to confirm the validity of the residues trials 
reported. Nevertheless, it is noted that further storage stability studies investigating a period of 24 
months in all relevant crop groups will be evaluated under Regulation (EU) No 1141/2010 (in view of 
the possible renewal of the approval of this active substance).  Review of the existing MRLs for thiabendazole 
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Table 3-2:  Overview of the available residues trials data  
Commodity  Residue 
region 
(a) 
Outdoor
/Indoor 
Individual trial results (mg/kg)  Median 
residue 
(mg/kg) 
(b) 
Highest 
residue 
(mg/kg) 
(c) 
MRL 
proposal 
(mg/kg) 
Median 
CF 
(d) 
Comments 
Enforcement  Risk assessment 
Residue definition for enforcement and risk assessment: thiabendazole 
Citrus fruit  EU  Indoor  Oranges: 0.40; 
0.53; 1.65; 1.25 
 
Mandarins: 0.65; 
0.50; 1.38; 1.60 
Oranges: 0.40; 
0.53; 1.65; 1.25 
 
Mandarins: 0.65; 
0.50; 1.38; 1.60 
0.95  1.65  4 
(g) 
(tentative) 
1.00  Trials on oranges (4) and 
mandarins (4) compliant with 
the drenching GAP; 
extrapolation to the whole group 
of citrus is conducted on a 
tentative basis (see body text). 
Rber = 3.09 
Rmax = 2.67 
MRLOECD = 3.10 
Apples 
Pears 
EU  Indoor  1.5
(i); 1.6; 1.7; 
1.7; 1.7
(i); 
1.7
(j);1.9
(i); 2.0 
 
1.5
(i); 1.6; 1.7; 
1.7; 1.7
(i); 
1.7
(j);1.9
(i); 2.0 
 
1.7  2.0  3 
(e) (g) 
(tentative) 
1.00  Underdosed trials on apple, 
within the 25 % deviation 
(Spain, 2014). 
Rber = 3.70 
Rmax = 2.23 
MRLOECD = 5.18 
Avocados 
Mangoes 
Import 
(KE) 
Indoor  4.80; 5.00; 5.60; 
6.00; 6.20; 6.50; 
6.70; 6.90; 7.00; 
7.00; 7.10; 7.80; 
8.00; 8.10; 8.10; 
8.50; 8.50; 8.80; 
8.90; 8.90; 10.30; 
11.00; 11.00; 
13.50 
4.80; 5.00; 5.60; 
6.00; 6.20; 6.50; 
6.70; 6.90; 7.00; 
7.00; 7.10; 7.80; 
8.00; 8.10; 8.10; 
8.50; 8.50; 8.80; 
8.90; 8.90; 10.30; 
11.00; 11.00; 
13.50 
7.90  13.50  20 
(f) (g) 
(tentative) 
1.00  Trials on avocados compliant 
with the GAP although residues 
determined on stoneless fruit. 
Rber = 17.75 
Rmax = 12.65 
MRLOECD = 23.78 
Bananas  EU  Indoor  -  -  -  -  -  1.00  No residue trials available. Review of the existing MRLs for thiabendazole 
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Commodity  Residue 
region 
(a) 
Outdoor
/Indoor 
Individual trial results (mg/kg)  Median 
residue 
(mg/kg) 
(b) 
Highest 
residue 
(mg/kg) 
(c) 
MRL 
proposal 
(mg/kg) 
Median 
CF 
(d) 
Comments 
Enforcement  Risk assessment 
Papaya  Import 
(US) 
Indoor  3.8; 3.5; 3.2; 3.8; 
5.1; 5.1; 4.2; 3.8 
3.8; 3.5; 3.2; 3.8; 
5.1; 5.1; 4.2; 3.8 
3.80  5.10  10 
(g) 
(tentative) 
1.00  Trials compliant with the GAP. 
Rber = 9.75 
Rmax = 6.3 
MRLOECD = 12.19 
Potatoes  EU  Indoor  2; 2.2; 2.4; 2.6; 
5.4; 5.4; 5.6; 8; 12 
2; 2.2; 2.4; 2.6; 
5.4; 5.4; 5.6; 8; 12 
5.40  12.00  15 
(g) 
(tentative) 
1.00  Trials compliant with the GAP. 
Rber = 13.6 
Rmax = 15.12 
MRLOECD = 18.33 
Residue definition for enforcement: thiabendazole 
Residue definition for risk assessment: sum of thiabendazole and benzimidazole expressed as thiabendazole 
Witloof  EU  Indoor  5x <0.05  -  0.05  0.05  0.05 
(g) 
(tentative) 
2.00
 (h)  Trials compliant with the GAP 
on chicory roots prior to forcing 
of witloof; trial results refer to 
witloof after forcing. 
(a):  NEU (Northern and Central Europe), SEU (Southern Europe and Mediterranean), EU (i.e outdoor use) or Import (country code) (EC, 2011). 
(b):  Median value of the individual trial results according to the enforcement residue definition. 
(c):  Highest value of the individual trial results according to the enforcement residue definition. 
(d):  The median conversion factor for enforcement to risk assessment is obtained by calculating the median of the individual conversion factors for each residues trial. 
(e):  MRL proposal on apples and pears is tentative because all available residue trials are underdosed. 
(f):  MRL proposal on avocados and mangoes is tentative due to the lack of analytical methods and adequate storage stability data for high oil content commodities, the absence of data on whole 
fruit (residue levels reported on stoneless fruits only) and the uncertainty regarding the reporting of duplicates values as individual trials. 
(g):  The residue definition is tentative in all plant commodities (see also section 3.1.1.1). 
(h):  Conversion factor for risk assessment is derived from the available metabolism studies in primary and rotational crops. 
(i):  The trial result at a sampling interval of 14-15 days was selected since it was found to be higher than the trial result at a sampling interval of 0 days. 
(j):  The trial result at a sampling interval of 30 days was selected since it was found to be higher than the trial result at a sampling interval of 0 days. 
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Consequently, the available residues data are considered sufficient to derive MRL proposals as well 
as  risk  assessment  values  for  all  commodities  under  evaluation,  except  for  bananas  where  the 
available data were insufficient to derive MRLs (see also Table 3-2). Considering that the residue 
definition in plants was derived on a tentative basis only, that a fully validated analytical method is 
still required for high oil content commodities, that further data are needed for regarding the residue 
trials  on  apples  and  avocado,  and  that  further  storage  stability  data  are  still  required,  all  MRL 
proposals should be considered on a tentative basis only.  
3.1.1.3.  Effect of industrial processing and/or household preparation 
The effect of processing on the nature of thiabendazole was investigated by the RMS after the Annex 
I  inclusion  and  it  was  concluded  that  processing  by  pasteurisation,  baking/brewing/boiling  and 
sterilisation is not expected to have a significant impact on the composition of residues in matrices of 
plant origin. This study was however not reported in detail to EFSA and a detailed evaluation report 
prepared  by  the  RMS  is  therefore  still  required.  This  data  gap  will  be  further  addressed  in  the 
framework of Regulation (EU) No 1141/2010 (in view of the possible renewal of the approval of this 
active substance). Meanwhile, the relevant residue for enforcement and risk assessment in processed 
commodities is tentatively concluded to be the same as for primary crops.  
Studies investigating the magnitude of residues in processed commodities of citrus fruits, potatoes and 
apples were assessed by JMPR (FAO, 2000). Additional trials investigating the magnitude of residues 
in peeled avocados and processed mushrooms were evaluated by the RMS after the Annex I inclusion. 
An overview of all available processing studies is available in Table 3-3. Based on the available data, 
a robust processing factor for enforcement and risk assessment can only be derived for peeled citrus 
fruits. No robust processing factors for enforcement and risk assessment could be derived  for the 
other processed commodities as they were not sufficiently supported by studies; a minimum of 3 
processing  studies  is  normally  required.  These  processing  factors  reported  in  Table  3-3  should 
therefore be considered as indicative only. 
Further processing trials are currently not required as they are not expected to affect the outcome of 
the risk assessment. However, if more robust processing factors were to be required by risk managers, 
in particular for enforcement purposes, additional processing studies would be needed. 
Table 3-3:  Overview of the available processing studies 
Processed commodity  Number 
of 
studies 
Median 
PF 
(a) 
Median 
CF 
(b) 
Comments 
Enforcement and risk assessment residue definition: thiabendazole 
Processing factors recommended (sufficiently supported by data) 
Citrus, peeled  8  0.01  1.00  Processing factors on oranges 
reported by JMPR (FAO, 2000). 
Indicative processing factors (limited dataset) 
Citrus, juice  2  0.09  1.00  Processing factors on oranges 
reported by JMPR (FAO, 2000). 
Citrus, dry pomace  2  5.7  1.00 
Citrus, wet pomace  2  1.2  1.00 
Oranges, marmalade  2  0.35  1.00 
Avocados, peeled  2  0.13  1.00  PROFile Review of the existing MRLs for thiabendazole 
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Processed commodity  Number 
of 
studies 
Median 
PF 
(a) 
Median 
CF 
(b) 
Comments 
Potatoes, peeled and boiled  2  0.07  1.00  Processing factors reported by 
JMPR (FAO, 2000). 
Potatoes, unpeeled and boiled  2  0.10  1.00 
Potatoes, peeled and microwaved  2  0.18  1.00 
Potatoes, unpeeled and microwaved  2  0.38  1.00 
Potatoes, fried  2  0.02  1.00 
Potatoes, crisps  2  0.01  1.00 
Apples, juice  1  0.54  1.00  Processing factors on apples 
reported by JMPR (FAO, 2000). 
Apples, dry pomace  1  4.90  1.00 
Apples, wet pomace  1  1.00  1.00 
Cultivated fungi, canned  1  1.19  1.00  PROFile 
Cultivated fungi, dried  1  9.97  1.00 
(a):  The  median  processing  factor  is  obtained  by  calculating  the  median  of  the  individual  processing  factors  of  each 
processing study. 
(b):  The median conversion factor for enforcement to risk assessment is obtained by calculating the median of the individual 
conversion factors of each processing study. 
 
3.1.2.  Rotational crops 
As the authorisations evaluated in the framework of this MRL review refer to post-harvest treatments, 
except for witloof which is not expected to be grown in rotation, further investigation of residues in 
rotational crops is not required. 
Although not required, the metabolism of thiabendazole in rotational crops – lettuce, turnip, wheat – 
has  been  evaluated  (Spain,  1996).  A  rotational  crop  study  investigating  the  nature  of  residues 
following different plant-back intervals is available. The characteristics of this study are summarised 
in Table 3-4. 
Table 3-4:  Summary of available metabolism studies in rotational crops 
Crop group  Crop  Label 
position 
Application and sampling details 
Method,  
F or G 
(a) 
Rate 
(kg 
a.s./ha) 
Sowing 
intervals 
(DAT) 
Harvest 
Intervals 
(DAT) 
Remarks 
Leafy vegetables   Lettuce 
14C-
phenyl 
Soil 
(b)  2.15 
(c)  30, 120, 
320 
95, 174, 
372 
- 
Root and tuber 
vegetables 
Turnip  95, 180, 
398  
- 
Cereals  Wheat  137, 223, 
408 
- 
(a):  Outdoor/field application (F) or glasshouse/protected/indoor application (G) 
(b):  F or G not stated 
(c):  3 plots treated either with 2 x 1.075 kg a.s./ha or 1 x 2.15 kg a.s./ha 
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Total residues in the rotational crops ranged from about 0.05 (wheat grain, 120-day plot) to 10 mg 
eq/kg (wheat straw, 320-day plot). Total residues in mature turnip tops and roots averaged 0.82 and 
0.15 mg eq/kg, respectively. Similarly, the total residues in wheat straw and grain averaged 6.55 and 
0.11 mg eq/kg, respectively. In lettuce, total residues declined from an average of 0.86 in immature 
leaves to 0.48 mg eq/kg in mature leaves, respectively.  
Parent thiabendazole was the major component in turnips roots (53-73 % TRR; 0.08-0.11 mg eq/kg), 
wheat  grain  (20-55.6  % TRR; 0.01-0.09 mg eq/kg), hulls (30.5-56.6 % TRR; 0.6-2.4 mg eq/kg), 
forage (23.2-47.2 % TRR; 0.13-0.66 mg eq/kg) and straw (24.9-37.1 % TRR; 0.89-2.55 mg eq/kg), as 
well as in turnips tops (35-49 % TRR; 0.04-0.42 mg eq/kg) and in lettuce (19-35 % TRR, 0.07-
0.23 mg eq/kg). 
The metabolite benzimidazole under free and conjugated forms (the latter being predominant) was 
also major in lettuce (33.3-62.7 % TRR; 0.09-0.81 mg eq/kg), and in turnip tops (35.3-41 % TRR; 
0.12-0.43 mg eq/kg). This compound was also detected in wheat forage (12.5-25.2 % TRR; 0.07-0.49 
mg eq/kg), hulls (12.3-28.4 % TRR; 0.57-1.87 mg eq/kg), straw (24.3-31.2 % TRR; 0.8-2.49 mg 
eq/kg) and grain (11.1-20 % TRR; 0.01-0.02 mg eq/kg). The metabolite 5-hydroxythiabendazole was 
detected in lettuce (6.4-14.8 % TRR; 0.04-0.10 mg eq/kg) and wheat forage (up to 8.9 % TRR; 
0.18 mg eq/kg). 
Based on the uses reported in the framework of this review, occurrence of residues through crop 
rotation is in any case not expected and a specific residue definition for rotational crops is not deemed 
necessary. However, the above data are considered adequate to demonstrate that also in the case of a 
very early application such as for witloof, benzimidazole might be present in amounts similar to the 
parent compound (see also section 3.1.1.). 
3.2.  Nature and magnitude of residues in livestock 
3.2.1.  Dietary burden of livestock 
Thiabendazole is authorised for use on several crops that might be fed to livestock. The median and 
maximum dietary burdens were therefore calculated for different groups of livestock using the agreed 
European methodology (EC, 1996). The input values for all relevant commodities have been selected 
according to the recommendations of JMPR (FAO, 2009) and are summarized in Table 3-5. For citrus 
and apple pomace, the indicative processing factor derived under section 3.1.1.3 has been included in 
the calculation. 
Table 3-5:  Input values for the dietary burden calculation  
Commodity  Median dietary burden  Maximum dietary burden 
Input value 
(mg/kg) 
Comment  Input value 
(mg/kg) 
Comment 
Risk assessment residue definition: thiabendazole 
Citrus pomace  1.14  Median residue x PF  1.14  Median residue x PF 
Apple pomace  1.70  Median residue x PF  1.70  Median residue x PF 
Potatoes  5.40  Median residue  12.00  Highest residue 
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The results of the calculations are reported in Table 3-6. The calculated dietary burdens for all groups 
of livestock were found to exceed the trigger value of 0.1 mg/kg DM. Further investigation of residues 
is therefore required in all commodities of animal origin. 
Table 3-6:  Results of the dietary burden calculation  
  Median 
dietary burden 
(mg/kg bw per d) 
Maximum 
dietary burden 
(mg/kg bw per d) 
Highest 
contributing 
commodity 
Max dietary 
burden 
(mg/kg DM) 
Trigger 
exceeded
(Y/N) 
Risk assessment residue definition: thiabendazole 
Dairy ruminants  0.420  0.900  Potatoes  25  Y 
Meat ruminants  1.021  2.152  Potatoes  50  Y 
Poultry  0.455  1.011  Potatoes  16  Y 
Pigs  0.864  1.920  Potatoes  48  Y 
 
3.2.2.  Nature of residues 
The  nature  of  thiabendazole  residues  in  commodities  of  animal  origin  was  investigated  in  the 
framework of Directive 91/414/EEC (Spain, 1996). Reported metabolism studies include one study in 
lactating  goats  and  one  study  in  laying  hens  using 
14C-phenyl  labelled  thiabendazole.  The 
characteristics of these studies are summarized in Table 3-7. 
Table 3-7:  Summary of available metabolism studies in livestock 
Group  Species  Label 
position 
No of 
animal 
Application details  Sample details 
Rate 
(mg/kg bw 
per d) 
Duration 
(days) 
Commodity  Time 
Lactating 
ruminants 
Goat 
14C-
phenyl 
3  2 – 2.7  7  Milk  Twice daily 
Urine and 
faeces 
Daily 
Tissues  At sacrifice 
Laying 
poultry 
Hens  25  1.6 – 3.2  10  Eggs  Twice daily 
Excreta  Daily 
Tissues  At sacrifice 
 
Lactating  goats  were  dosed  with  2  –  2.7  mg/kg  bw  per  d  of  thiabendazole,  corresponding  to 
approximately  0.9  –  1.3  times  the  exposure  of  meat  ruminant.  This  study  demonstrates  that 
thiabendazole was mainly excreted (98 % AR in the excreta) and that transfer of residues to milk and 
tissues was relatively low (1 % AR in milk and tissues), although the absolute residue levels in tissues 
are not negligible; the highest TRR values amounted to 4.77 mg eq/kg in liver and 1.39 mg eq/kg in 
kidney. Other TRR values  amounted to 1.02 mg eq/kg in milk (whole study mean value, with a 
plateau of 1.13 mg eq/kg reached after 3 days), 0.1 mg eq/kg in muscle and 0.03 mg eq/kg in fat. Review of the existing MRLs for thiabendazole 
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Parent thiabendazole represented less than 5 % TRR in all matrices (0.2 mg eq/kg in liver; 0.07 mg 
eq/kg in kidney and <0.01 mg eq/kg in milk and muscle). Metabolite 5-hydroxythiabendazole (free 
form) was the most abundant compound in kidney (41.4 % TRR; 0.57 mg eq/kg) and in muscle 
(10.5 % TRR; 0.01 mg eq/kg) and it also accounted for 0.12 mg eq/kg (2.5 % TRR) in liver. The O-
sulfate conjugate of 5-hydroxythiabendazole
14 was the most abundant compound in milk (39 % TRR; 
0.40 mg eq/kg) but it did not account for more than 2 % TRR (<0.01 mg eq/kg) in other matrices. In 
addition, the metabolite benzimidazole was detected  in kidney (24.7 % TRR; 0.34 mg eq/kg), liver 
(1.8 % TRR; 0.09 mg eq/kg) and at levels below 0.01 mg eq/kg in muscle and milk.  
Laying  hens  were  dosed  with  1.6  –  3.2  mg/kg  bw  per  d  of  thiabendazole,  corresponding  to 
approximately 1.6 – 3.2 times the exposure of poultry. This study demonstrates that thiabendazole 
was mainly excreted (99.6 % AR in the excreta) and that transfer of residues to eggs and tissues is 
relatively low. The total residues in eggs reached a level of about 0.1 mg eq/kg by day 2 and remained 
steady throughout the next 8 days. The highest TRR was detected in liver (1.5 mg eq/kg), TRR levels 
in muscle (0.1 mg eq/kg), eggs (0.1 mg eq/kg) and fat (0.02 mg eq/kg) being significantly lower. 
5-hydroxythiabendazole was the most abundant compound in egg (30 % TRR; 0.03 mg eq/kg) and in 
liver (4.8 % TRR; 0.07 mg eq/kg), parent thiabendazole accounting for 10 % TRR in eggs (0.01 mg 
eq/kg) and for 3.4 % TRR in liver (0.05 mg eq/kg). Benzamidazole was also detected in eggs (20 % 
TRR; 0.02 mg eq/kg) and in liver (2 % TRR; 0.03 mg eq/kg). No compound above 0.01 mg eq/kg was 
identified in muscle or fat. 
The metabolism studies on both ruminant and poultry show that 5-hydroxythiabendazole is the main 
component of the residue in animal tissues and products. The general metabolic pathways in rodents 
and ruminants were found to be comparable; the findings in ruminants can therefore be extrapolated 
to pigs.  
Nevertheless,  EFSA  highlights  that  the  metabolite  benzimidazole  occurs  at  a  significant  level  in 
ruminant kidney (25 % TRR; 0.343 mg/kg) and in eggs (20 % TRR; 0.02 mg/kg). This metabolite was 
not analysed for in the feeding studies and was not identified in the rat metabolism (only the 2-
acetylbenzimidazole
15 was recovered in urine at a low level).  Consequently, further information on 
the toxicity of benzimidazole is required.  In addition, the detection of  benzimidazole shows that a 
cleavage of thiabendazole occurs. Consequently, investigation of the fate of thiazolyl moiety in 
ruminants and poultry is required. These data gaps should be further addressed in the framework of 
Regulation (EU) No 1141/2010 (in view of the possible renewal of the approval of this active 
substance). 
Moreover, identification in ruminant and poultry liver was limited (respectively 8 and  10 % TRR), 
whereas  extraction  rate s  reported  in  the  DAR  are  high  (93.6  %  TRR).  Clarification  on  the 
characterisation of unidentified residues in liver is therefore required. 
Meanwhile, the residue for enforcement in  tissues and eggs  is  tentatively  defined  as the sum of 
thiabendazole and 5-hydroxythiabendazole, expressed as thiabendazole for all types of livestock. For 
risk assessment purposes, it is proposed to also include benzimidazole in the residue definition.  In 
milk it is proposed to define the resid ue for both enforcement and risk assessment  as the sum of 
thiabendazole,  5-hydroxythiabendazole  and  its  sulphate  conjugate ,  expressed  as  thiabendazole . 
Validated analytical methods for enforcement of the proposed residue  definition are  currently not 
available (see also section 1.2). 
                                                       
14 2-(1,3-thiazol-4-yl)-1H-benzimidazol-5-yl hydrogen sulphate. See Appendix E. 
15 1-(1H-benzimidazol-2-yl)ethanone. See Appendix E. Review of the existing MRLs for thiabendazole 
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3.2.3.  Magnitude of residues 
During  the  peer  review  under  Directive  91/414/EEC,  the  magnitude  of  thiabendazole residues in 
ruminants and poultry was investigated in two feeding studies with lactating cows and laying hens 
(Spain, 1996). Three groups of lactating cows, each consisting of three animals were dosed for 28 
consecutive days with thiabendazole at levels of 25, 75 and 250 mg/kg in the diet (equivalent to 0.9, 
2.7 and 9.1 mg/kg bw). Four groups of laying hens, each consisting of fifty animals were dosed for 7 
consecutive weeks with thiabendazole at levels of 2, 20, 200 and 2000 mg/kg in the diet (equivalent to 
0.13,  1.3,  12.6  and  126.3  mg/kg  bw).  The  samples  were  analysed  for  thiabendazole  and  5-
hydroxythiabendazole. In milk, a plateau level was reached after 2 days of exposure but it is not clear 
whether  the  analytical  method  used  on  milk  samples  includes  the  sulphate  conjugate  of  5-
hydroxythiabendazole. In the absence of that information, it is assumed that the conjugate was dosed. 
Moreover, no results were reported for benzimidazole and a livestock feeding study investigating all 
compounds included in the residue definition for risk assessment is still required. Meanwhile, results 
of the available livestock feeding studies are summarised in Table 3-8. The individual results for 
tissues, milk and eggs were not available and EFSA understands that only the highest residue for 
ruminants and poultry tissues and the highest daily mean for milk were reported. Similarly, only one 
value was available for eggs and it couldn’t be determined whether it is a maximum or a mean. 
Consequently, an evaluation report including detailed results of the reported feeding studies is still 
required.  
The storage stability of thiabendazole residues in animal products was evaluated by JMPR (FAO, 
1997). Studies demonstrated storage stability of thiabendazole and 5-hydroxythiabendazole in milk, 
eggs, muscle, liver and kidney and sulphate conjugate of 5-hydroxythiabendazole in milk for up to 2 
months when stored deep frozen. However, the storage conditions of the samples from the livestock 
feeding  studies  were  not  reported  by  the  RMS  and  information  on  the  storage  stability  of 
thiabendazole and 5-hydroxythiabendazole in fat is also not available Nevertheless, it is noted that 
further storage stability studies investigating a period of 24 months in all relevant commodities will be 
evaluated under Regulation (EU) No 1141/2010 (in view of the possible renewal of the approval of 
this active substance). 
Consequently, the available data are considered sufficient for deriving MRLs in ruminants, pigs and 
hens. These MRLs were derived in compliance with the latest recommendations on this matter (FAO, 
2009) and are summarized in Table 3-7. In the absence of the mean residue levels in tissues, milk and 
eggs, calculations were based on the highest values which is expected to overestimate residues in 
commodities  of  animal  origin  as  well  as  the  resulting  exposure  (worst-case  assumption).  In  the 
absence of results for benzimidazole, conversion factors for enforcement to risk assessment reported 
in the table were derived from the available metabolism studies. Considering however that the residue 
definition was derived on a tentative basis only and that further data on analytical methods, livestock 
feeding and storage stability are still required, these MRLs and risk assessment values (including 
conversion factors for risk assessment) are tentative only. Review of the existing MRLs for thiabendazole 
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Table 3-8:  Overview of the values derived from the livestock feeding studies  
Commodity  Dietary burden  Results of the livestock feeding study  Median 
residue 
(mg/kg) 
(c) 
Highest 
residue 
(mg/kg) 
(d) 
MRL 
proposal 
(mg/kg) 
(e) 
CF for 
RA 
Med. 
(mg/kg bw 
per d) 
Max. 
(mg/kg bw 
per d) 
Dose 
Level 
(mg/kg bw 
per d) 
(a) 
No   Result for enf.  Result for RA 
Mean 
(b) 
(mg/kg) 
Max. 
(mg/kg) 
Mean 
(mg/kg) 
Max. 
(mg/kg) 
Enforcement residue definition: sum of thiabendazole and 5-hydroxythiabendazole, expressed as thiabendazole 
Risk assessment residue definition: sum of thiabendazole, 5-hydroxythiabendazole and benzimidazole, expressed as thiabendazole 
Pig muscle  0.864  1.920  1.07  3  n.r.  0.02  Not available  0.01  0.02  0.02 
(tentative) 
1.50
 (f) 
3.21  3  n.r.  0.02 
10.71  3  n.r.  0.02 
Pig fat  1.07  3  n.r.  0.02  0.02  0.02  0.03 
(tentative) 
1.00
 (f) 
3.21  3  n.r.  0.03 
10.71  3  n.r.  0.03 
Pig liver  1.07  3  n.r.  0.05  0.04  0.10  0.15 
(tentative) 
1.30
 (f) 
3.21  3  n.r.  0.19 
10.71  3  n.r.  0.24 
Pig kidney  1.07  3  n.r.  0.05  0.04  0.20  0.3 
(tentative) 
1.50
 (f) 
3.21  3  n.r.  0.44 
10.71  3  n.r.  0.58 Review of the existing MRLs for thiabendazole 
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Commodity  Dietary burden  Results of the livestock feeding study  Median 
residue 
(mg/kg) 
(c) 
Highest 
residue 
(mg/kg) 
(d) 
MRL 
proposal 
(mg/kg) 
(e) 
CF for 
RA 
Med. 
(mg/kg bw 
per d) 
Max. 
(mg/kg bw 
per d) 
Dose 
Level 
(mg/kg bw 
per d) 
(a) 
No   Result for enf.  Result for RA 
Mean 
(b) 
(mg/kg) 
Max. 
(mg/kg) 
Mean 
(mg/kg) 
Max. 
(mg/kg) 
Enforcement residue definition: sum of thiabendazole and 5-hydroxythiabendazole, expressed as thiabendazole 
Risk assessment residue definition: sum of thiabendazole, 5-hydroxythiabendazole and benzimidazole, expressed as thiabendazole 
Ruminant muscle  1.021 
 
2.152 
 
1.07  3  n.r.  0.02  Not available  0.02  0.02  0.02 
(tentative) 
1.50
 (f) 
3.21  3  n.r.  0.02 
10.71  3  n.r.  0.02 
Ruminant fat  1.07  3  n.r.  0.02  0.02  0.03  0.03 
(tentative) 
1.00
 (f) 
3.21  3  n.r.  0.03 
10.71  3  n.r.  0.03 
Ruminant liver  1.07  3  n.r.  0.05  0.05  0.12  0.15 
(tentative) 
1.30
 (f) 
3.21  3  n.r.  0.19 
10.71  3  n.r.  0.24 
Ruminant kidney  1.07  3  n.r.  0.05  0.05  0.25  0.3 
(tentative) 
1.50
 (f) 
3.21  3  n.r.  0.44 
10.71  3  n.r.  0.58 
Enforcement and risk assessment residue definition: sum of thiabendazole,5-hydroxythiabendazole and its sulphate conjugates, expressed as thiabendazole 
Milk  0.420  0.900  0.90  21  0.03
(g)  n.a.  See results for 
enforcement 
0.01  0.03  0.03 
(tentative) 
1.00 
2.72  21  0.12
(g)  n.a. 
9.09  21  0.15
(g)  n.a. Review of the existing MRLs for thiabendazole 
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Commodity  Dietary burden  Results of the livestock feeding study  Median 
residue 
(mg/kg) 
(c) 
Highest 
residue 
(mg/kg) 
(d) 
MRL 
proposal 
(mg/kg) 
(e) 
CF for 
RA 
Med. 
(mg/kg bw 
per d) 
Max. 
(mg/kg bw 
per d) 
Dose 
Level 
(mg/kg bw 
per d) 
(a) 
No   Result for enf.  Result for RA 
Mean 
(b) 
(mg/kg) 
Max. 
(mg/kg) 
Mean 
(mg/kg) 
Max. 
(mg/kg) 
Enforcement residue definition: sum of thiabendazole and 5-hydroxythiabendazole, expressed as thiabendazole 
Risk assessment residue definition: sum of thiabendazole, 5-hydroxythiabendazole and benzimidazole, expressed as thiabendazole 
Poultry muscle  0.455  1.011  1.26  50  n.r.  0.02  Not available  0.01  0.02  0.02 
(tentative) 
1.00
 (f) 
12.63  50  n.r.  0.07 
126.31  50  n.r.  0.90 
Poultry fat  1.26  50  n.r.  0.03  0.01  0.02  0.03 
(tentative) 
1.00
 (f) 
12.63  50  n.r.  0.12 
126.31  50  n.r.  1.04 
Poultry liver  1.26  50  n.r.  0.08  0.03  0.06  0.07 
(tentative) 
1.20
 (f) 
12.63  50  n.r.  0.63 
126.31  50  n.r.  5.80 
Eggs  1.26  n.r.  n.r.  0.05  0.02  0.04  0.05 
(tentative) 
1.50
 (f) 
12.63  n.r.  n.r.  1.63 
126.31  n.r.  n.r.  2.57 
n.a.: Not applicable – only the mean values are considered for calculating MRLs in milk. 
n.r.: Not reported. 
(a):  Based on a 550 kg cow consuming 20 kg feed DM/day and a 1.9 kg hen consuming 0.12 kg feed DM/day. 
(b):  Mean residues were not reported; highest residue is used in the absence of the individual values. 
(c):  Median residue value according to the enforcement residue definition, derived by interpolation/extrapolation from the feeding study for the median dietary burden (FAO, 2009). 
(d):  Highest residue value (tissues, eggs) or mean residue value (milk) according to the enforcement residue definition, derived by interpolation/extrapolation of the maximum dietary burden 
between the relevant feeding groups of the study (FAO, 2009). 
(e):  The median conversion factor for enforcement to risk assessment. 
(f):  In the absence of livestock feeding results for benzimidazole, tentative conversion factors were derived on the basis of the available metabolism studies. 
(g):  Highest residue level from day 1 until day 28 (daily mean of 3 cows) which was used in the absence of the individual values. 
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4.  Consumer risk assessment 
In the framework of this review, only the uses of thiabendazole reported by the RMS in Appendix A 
were considered, however the use of thiabendazole was previously also assessed by the JMPR (FAO, 
1997, 2000, 2006). The CXLs, resulting from these assessments by JMPR and adopted by the CAC, 
are now international recommendations that need to be considered by European risk managers when 
establishing MRLs. In order to facilitate consideration of these CXLs by risk managers, the consumer 
exposure was calculated both with and without consideration of the existing CXLs (see Appendix 
C.2). 
In addition, MRLs in products of animal origin resulting from the use of thiabendazole as a veterinary 
medicine are also established in the framework of Regulation (EU) N° 37/2010 (see Appendix C.3). 
In order to facilitate consideration of these veterinary MRLs by risk managers, further consideration 
was given to these MRLs in a separate section. 
EFSA highlights that the consumer risk assessment is based on the toxicological reference values 
currently established by the European Commission which may be modified in the near future as a 
result of the peer review under Regulation (EU) No 1141/2010 (in view of the possible renewal of the 
approval of this active substance). If applicable, the consumer risk assessment for all crops reported in 
the framework of this review (including the CXLs) will need to be reconsidered. 
4.1.  Consumer risk assessment without consideration of CXLs or veterinary MRLs 
Chronic exposure calculations for all crops supported in the framework of this review were performed 
using revision 2 of the EFSA Pesticide Residues Intake Model (PRIMo) (EFSA, 2007). Input values 
for the exposure calculations were derived in compliance with Appendix D and are summarized in 
Table 4-1. The (tentative) median residue values selected for chronic intake calculations are based on 
the residue levels in the raw agricultural commodities reported in section 3, except for citrus and 
avocados  where  the  peeling  factors  derived  under  section  3.1.1.3  have  been  included  in  the 
calculation.  For  bananas,  where  data  were  insufficient  to  derive  an  MRL  in  section  3,  EFSA 
considered  the  existing  EU  MRL  for  an  indicative  calculation.  The  contributions  of  other 
commodities, for which no GAP was reported in the framework of this review, were not included in 
the calculation. Acute exposure calculations were not carried out because an ARfD was not deemed 
necessary for this active substance. 
Table 4-1:  Input  values  for  the  consumer  risk  assessment  (without  consideration  of  CXLs  or 
veterinary MRLs) 
Commodity  Chronic risk assessment 
Input value (mg/kg)  Comment 
Risk assessment residue definition: thiabendazole 
Citrus fruit  0.01  Median residue x PF (tentative)
 (a) 
Apples, pears  1.70  Median residue (tentative)
 (a) 
Avocados  1.03  Median residue x PF (tentative)
 (a) 
Bananas  5.00  EU MRL
 (b) 
Mangoes  7.90  Median residue (tentative)
 (a) 
Papaya  3.80  Median residue (tentative)
 (a) 
Potatoes  5.40  Median residue (tentative)
 (a) Review of the existing MRLs for thiabendazole 
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Commodity  Chronic risk assessment 
Input value (mg/kg)  Comment 
Risk assessment residue definition: sum of thiabendazole and benzimidazole, expressed as thiabendazole 
Witloof  0.10  Median residue x CF (tentative)
 (a) 
Risk  assessment  residue  definition:  sum  of  thiabendazole,  5-hydroxythiabendazole  and  benzimidazole, 
expressed as thiabendazole 
Swine meat  0.02  Median muscle x CF (tentative) 
 (c) 
Swine fat (free of lean meat)  0.02  Median residue (tentative) 
(c) 
Swine liver  0.05  Median residue x CF (tentative) 
(c) 
Swine kidney  0.06  Median residue x CF (tentative) 
(c) 
Ruminant meat  0.02  Median muscle x CF (tentative) 
(c) 
Ruminant fat  0.02  Median residue (tentative) 
(c) 
Ruminant liver  0.06  Median residue x CF (tentative) 
(c) 
Ruminant kidney  0.07  Median residue x CF (tentative) 
(c) 
Poultry meat  0.01  Median muscle (tentative) 
(c) 
Poultry fat  0.01  Median residue (tentative) 
(c) 
Poultry liver  0.04  Median residue x CF (tentative) 
(c) 
Birds' eggs  0.03  Median residue x CF (tentative) 
(c) 
Risk  assessment  residue  definition:  sum  of  thiabendazole,  5-hydroxythiabendazole  and  its  sulphate 
conjugates, expressed as thiabendazole 
Ruminant milk  0.01  Median residue (tentative) 
(c) 
(a):  Use reported by the RMS is not fully supported by data but the risk assessment value derived in section 3 is used for 
indicative exposure calculations. 
(b):  Use reported by the RMS is not supported by data; the existing EU MRL is used for indicative exposure calculations. 
(c):  Dietary burden relevant to this commodity of animal origin, resulting from the GAPs reported by the RMS, is not fully 
supported by data; the risk assessment values derived in section 3 are used for indicative exposure calculations (also 
assuming the existing residue definition). 
 
The  calculated  exposures  were  compared  with  the  toxicological  reference  value  derived  for 
thiabendazole (see Table 2-1); detailed results of the calculations are presented as the EU scenario in 
Appendix B.1. The highest chronic exposure was calculated for Dutch children, representing 52.7 % 
of the ADI. 
Based  on  the  above  calculations,  major  uncertainties  remain  due  to  the  data  gaps  identified  in 
section 3 but considering tentative MRLs or existing EU MRLs in the exposure calculation did not 
indicate a risk to consumers. 
4.2.  Consumer risk assessment with consideration of CXLs 
In order to include the CXLs in the calculations of the consumer exposure, all data relevant to the 
consumer exposure assessment have been collected from JMPR evaluations and reported in Appendix 
C.2 to this document. These CXLs were compared with the EU MRL proposals in compliance with 
Appendix D and input values resulting from this comparison are summarized in Table 4-2. 
All CXLs, except for cattle milk (see below), refer to the same residue definitions than the ones 
proposed on a tentative basis at EU level. Concerns regarding the nature of the residue in plants and 
livestock  products  identified  by  EFSA  (see  also  sections  3.1.1.1  and  3.2.2)  are  therefore  also Review of the existing MRLs for thiabendazole 
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applicable  to  the  residue  definitions  derived  by  JMPR.  CXLs  are  therefore  considered  as  not 
adequately supported by data. 
Regarding the CXL in cattle milk, the residue definition for enforcement is restricted to the sum of 
thiabendazole and 5-hydroxythiabendazole, which is not compliant with the residue definition for 
enforcement proposed in this review. Nevertheless, EFSA notes that according to JMPR, the MRL 
and risk assessment values for milk were derived on the basis of the same feeding study than the one 
reported  in  this  review  and  that  it  was  also  assumed  that  the  analytical  method  used  for  milk 
hydrolysed the sulphate conjugate to 5-hydroxythiabendazole (FAO, 2000). Consequently, even if not 
reported  as  such,  the  CXL value can be considered as expressed in accordance with the residue 
definition for enforcement proposed in this review. 
EFSA also noticed that JMPR has proposed CXLs for products of bovine origin only while no CXLs 
were proposed for other ruminants, swine or poultry liver. Considering that citrus fruits are the only 
feed items with a higher CXL than the MRL proposed at EU level and that this feed commodity is not 
consumed by swine or poultry, CXLs for bovine were considered applicable to other ruminants too.   
Table 4-2:  Input values for the consumer risk assessment (with consideration of CXLs) 
Commodity  Chronic risk assessment 
Input value (mg/kg)  Comment 
Risk assessment residue definition: thiabendazole 
Citrus fruit  0.27  Median residue (CXL) x PF
 (tentative)
 (a) 
Apples, pears  1.70  Median residue (tentative) 
(b) 
Quinces  1.70  Median residue (CXL) (tentative) 
(a) 
Medlar  1.70  Median residue (CXL) (tentative)
 (a) 
Loquat  1.70  Median residue (CXL) (tentative)
 (a) 
Avocados  1.03  Median residue x PF (tentative) 
(b) 
Bananas  5.00  EU MRL
 (c) 
Mangoes  7.90  Median residue (tentative) 
(b) 
Papaya  3.80  Median residue (tentative)
 (b) 
Potatoes  5.40  Median residue
 (tentative)
 (b) 
Cultivated fungi  31.00  Median residue (CXL) (tentative)
 (a) 
Risk assessment residue definition: sum of thiabendazole and benzimidazole, expressed as thiabendazole 
Witloof  0.10  Median residue x CF
 (tentative)
 (b) 
Risk  assessment  residue  definition:  sum  of  thiabendazole,  5-hydroxythiabendazole  and  benzimidazole, 
expressed as thiabendazole 
Swine meat  0.02  Median muscle x CF (tentative)
 (d) 
Swine fat (free of lean 
meat) 
0.02  Median residue (tentative) 
(d) 
Swine liver  0.05  Median residue x CF 
 (tentative)
 (d) 
Swine kidney  0.06  Median residue (tentative) x CF (tentative)
 (d) 
Ruminant meat  0.03  Median muscle (CXL) x CF 
 (tentative)
 (e) 
Ruminant fat  0.02  Median residue (CXL) (tentative) 
(e) Review of the existing MRLs for thiabendazole 
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Commodity  Chronic risk assessment 
Input value (mg/kg)  Comment 
Ruminant liver  0.26  Median residue (CXL) x CF (tentative)
 (e) 
Ruminant kidney  0.75  Median residue (CXL) x CF (tentative)
 (e) 
Poultry meat  0.05  Median residue (CXL) (tentative)
 (a) 
Poultry fat  0.05  Median residue (CXL) (tentative) 
(a) 
Poultry liver  0.04  Median residue x CF (tentative) 
(d) 
Birds' eggs  0.15  Median residue (CXL) x CF (tentative)
 (a) 
Risk  assessment  residue  definition:  sum  of  thiabendazole,5-hydroxythiabendazole  and  its  sulphate 
conjugate, expressed as thiabendazole 
Ruminant milk  0.12  Median residue (CXL) x CF (tentative) 
(e) 
(a):  CXL is not adequately supported by data;  the corresponding risk assessment value is used for indicative exposure 
calculations (also assuming the existing residue definition). 
(b):  Use reported by the RMS is not fully supported by data but the risk assessment value derived in section 3 is used for 
indicative exposure calculations (also assuming the existing residue definition). 
(c):  Use reported by the RMS is not supported by data; the existing EU MRL is used for indicative exposure calculations. 
(d):  Dietary burden relevant to this commodity of animal origin, resulting from the GAPs reported by the RMS, is not fully 
supported by data; the risk assessment values derived in section 3 are used for indicative exposure calculations (also 
assuming the existing residue definition). 
(e):  CXL for bovine is not adequately supported by data; the corresponding risk assessment value is used for indicative 
exposure calculations in all ruminants (also assuming the existing residue definition). 
 
Chronic and acute exposure calculations were also performed using revision 2 of the EFSA PRIMo 
and  calculated  exposures  were  compared  with  the  toxicological  reference  value  derived  for 
thiabendazole (see Table 2-1); detailed results of the calculations are presented as the EU/Codex 
scenario  in  Appendix  B.2.  The  highest  chronic  exposure  was  calculated  for  Dutch  children, 
representing 60.9 % of the ADI. 
Based on the above calculations, EFSA concludes that uncertainties remain for all CXLs as they are 
not well supported by data. Nevertheless, inclusion of these CXLs in the exposure calculation did not 
indicate any risk to European consumers. 
4.3.  Consumer risk assessment with consideration of the veterinary MRLs 
MRLs  for  thiabendazole  in  products  of  animal  origin  are  also  established  in  the  framework  of 
Regulation (EU) N° 37/2010 (see Appendix C.3). These MRLs result from the use of thiabendazole as 
a veterinary medicine in cattle and goat (EMA, 2004). In order to include the veterinary MRLs in the 
calculations of the consumer exposure, these MRLs should be compared with the EU MRL proposals 
for  commodities  from  animal  origin.  However,  these  veterinary  MRLs  are  set  at  the  limit  of 
quantification available at the time when they were proposed (0.1 mg/kg). It is therefore unclear if 
quantifiable  residues  of  thiabendazole  are  expected  in  animal  commodities  following  its  use  as 
veterinary drug and no further information can be retrieved in the reports from EMA. Nevertheless, 
the MRLs derived from the pesticide use are equal to or higher than the veterinary MRLs for all 
commodities. 
Consequently,  EFSA  concludes  that  the  veterinary  MRLs  are  not  expected  to  be  of  concern  for 
European consumers. The possible aggregated exposure from thiabendazole residues resulting from 
both pesticide and veterinary uses was not calculated but the  proposed EU MRLs are considered 
sufficiently protective by EFSA. Review of the existing MRLs for thiabendazole 
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CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
The toxicological profile of thiabendazole was evaluated in the framework of Directive 91/414/EEC, 
which  resulted  in  an  ADI  being  established  at  0.1  mg/kg  bw  per  d.  An  ARfD  was  not  deemed 
necessary. 
Primary crop metabolism of thiabendazole was investigated in four different crop groups following 
foliar  or  post-harvest  applications.  Results  indicate  that  following  post-harvest  treatment 
thiabendazole is the only relevant compound while following a pre-harvest application benzimidazole 
may be present at levels similar to the parent compound. This metabolite was not identified in the rat 
metabolism  and  further  information  on  the  toxicity  of  benzimidazole  is  required.  Moreover,  no 
justification was provided for not investigating the thiazolyl moiety of the compound. These data gaps 
will be further discussed under Regulation (EU) No 1141/2010 (in view of the possible renewal of the 
approval  of  this  active  substance).  Meanwhile,  the  relevant  residue  for  enforcement  and  risk 
assessment in all plant commodities following post-harvest treatments could be tentatively defined as 
thiabendazole only. It is also proposed to include benzimidazole in the residue definition for risk 
assessment of witloof which is the only crop reported in the framework of this review subject to a pre-
harvest treatment. Validated analytical methods for enforcement of the proposed residue definition are 
available with an LOQ of 0.01 mg/kg in high water content and acidic commodities. However, an 
analytical method with its ILV and with a confirmatory method fully validated for the determination 
of thiabendazole in high oil content commodities are still required. 
Regarding the magnitude of residues in primary crops, available residues trials data are sufficient to 
derive MRL proposals as well as risk assessment values for all commodities under evaluation, except 
for  bananas  where  the  available  data  were  insufficient  to  derive  MRLs  (see  also  Table  3-2). 
Considering that the residue definition in plants was derived on a tentative basis only, that a fully 
validated analytical method is still required for high oil content commodities, that further data are 
needed regarding the residue trials on apples and avocado, and that further storage stability data are 
still required, all MRL proposals should be considered on a tentative basis only. 
In  processed  commodities,  thiabendazole  residues  were  shown to be stable during pasteurisation, 
cooking, brewing and sterilisation. A detailed evaluation of this study is however still required in the 
framework of Regulation (EU) No 1141/2010. Meanwhile, the relevant residue for enforcement and 
risk assessment in processed commodities is expected to be the same as for primary crops. Magnitude 
of residues in processed commodities was also investigated and robust processing factors could only 
be derived for peeled citrus. With regard to the risk assessment, further processing studies are not 
required because they are not expected to affect the outcome of the risk assessment. However, if there 
would  be  the  intention  from  risk  managers  to  derive  more  processing  factors  for  enforcement 
purposes, additional processing studies might be required. 
Although  not required, the potential incorporation of soil residues into succeeding and rotational 
crops was investigated in turnip, lettuce and wheat. These studies showed a comparable metabolism 
as the one in primary crops. Based on the uses reported in the framework of this review, occurrence of 
residues through crop rotation is in any case not expected. 
Based on the uses reported by the RMS, significant intakes were calculated for ruminants, poultry and 
pigs. Metabolism in lactating ruminants and poultry was investigated and findings can be extrapolated 
to  pigs  as  well.  The  residue  for  enforcement  of  all  tissues  and  eggs  was  defined  as  the  sum  of 
thiabendazole and 5-hydroxythiabendazole, expressed as thiabendazole. For risk assessment purposes, 
it is proposed to also include benzimidazole in the residue definition. In milk, EFSA proposed to 
define  the  residue  for  both  enforcement  and  risk  assessment  as  the  sum  of  thiabendazole,  5-
hydroxythiabendazole and its sulphate conjugate, expressed as thiabendazole. However, these residue Review of the existing MRLs for thiabendazole 
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definitions are considered tentative  because further information on the toxicological properties of 
benzimidazole and further data on the fate of the thiazolyl moiety in ruminants and poultry are still 
required. These data gaps will be further discussed under Regulation (EU) No 1141/2010 (in view of 
the possible renewal of the approval of this active substance). Moreover, validated analytical methods 
for enforcement of these residue definitions are not available and are therefore required. The available 
livestock feeding studies on lactating cows and laying hens allowed EFSA to estimate the magnitude 
of  residues  in  ruminants,  poultry  and  pig  products  and  to  derive  MRLs  in  these  commodities. 
Considering however that the residue definition was derived on a tentative basis only and that further 
data on analytical methods, livestock feeding and storage stability are still required, these MRLs are 
tentative only.  
Chronic consumer exposure resulting from the  authorised  uses reported in the framework of this 
review  was  calculated  using  revision  2  of  the  EFSA  PRIMo.  For  bananas,  where  data  were 
insufficient to derive an MRL, EFSA considered the existing EU MRL for an indicative calculation. 
The  highest  chronic  exposure  represented  52.7  %  of  the  ADI  (Dutch  children).  Acute  exposure 
calculations  were  not  carried  out  because  an  ARfD  was  not  deemed  necessary  for  this  active 
substance. 
Apart from the MRLs evaluated in the framework of this review, internationally recommended CXLs 
have  also  been  established  for  thiabendazole.  Additional  calculations  of  the  consumer  exposure, 
considering these CXLs, were therefore carried out and the highest chronic exposure represented 
60.9 % of the ADI (Dutch children). 
MRLs  for  thiabendazole  in  products  of  animal  origin  are  also  established  in  the  framework  of 
Regulation (EU) N° 37/2010. These veterinary MRLs, resulting from the use of thiabendazole as a 
veterinary medicine in cattle and goat, are lower than or equal to the MRLs derived from the pesticide 
use for all commodities. Consequently, EFSA concludes that the veterinary MRLs are not expected to 
be of concern for European consumers. 
EFSA highlights that the consumer risk assessment is based on the toxicological reference values 
currently established by the European Commission which may be modified in the near future as a 
result  of  the peer review under Regulation (EU) No 1141/2010. If applicable, the consumer risk 
assessment for all crops reported in the framework of this review (including the CXLs) will need to be 
reconsidered. 
RECOMMENDATIONS 
Based on the above assessment, EFSA does not recommend inclusion of this active substance in 
Annex IV to Regulation (EC) No 396/2005. MRL recommendations were derived in compliance with 
the decision tree reported in Appendix D (see summary table). None of the MRL values listed in the 
table  are  recommended  for  inclusion  in  Annex  II  to  the  Regulation  as  they  are  not  sufficiently 
supported by data (see summary table footnotes for details). In particular, certain tentative MRLs or 
existing EU MRLs still need to be confirmed by the following data: 
  a validated analytical method (with its ILV and a confirmatory method) for the determination 
of thiabendazole in high oil content commodities; 
  a validated analytical method (with its ILV and a confirmatory method) for the determination 
of the sum of thiabendazole and 5-hydroxythiabendazole in animal tissues and eggs; 
  a validated analytical method (with its ILV and a confirmatory method) for the determination 
of the sum of thiabendazole, 5-hydroxythiabendazole and its sulphate conjugates in milk; 
  further  data  on  the  toxicological  properties  of  benzimidazole  (to  be  addressed  under 
Regulation (EU) No 1141/2010); Review of the existing MRLs for thiabendazole 
 
EFSA Journal 2014;12(7):3750  33 
  further  data  on  the  fate  of  the  thiazolyl  moiety  in  plants,  ruminants  and  poultry  (to  be 
addressed under Regulation (EU) No 1141/2010); 
  additional  residues  trials  supporting with the authorised GAP  on apples and pears (to be 
addressed under Regulation (EU) No 1141/2010); 
  4 residue trials supporting the post-harvest GAP on bananas; 
  a detailed report on the supporting residue trials on avocado in order to identify independent 
trials and propose a correction factor to convert the data on stoneless fruit to whole fruit; 
  a study investigating the storage stability of thiabendazole (to be addressed under Regulation 
(EU) No 1141/2010); 
  a detailed evaluation of the hydrolysis study investigating nature of residues in processed 
commodities (to be addressed under Regulation (EU) No 1141/2010); 
  clarification on the characterisation of unidentified residues in ruminant and poultry liver (to 
be addressed under Regulation (EU) No 1141/2010); 
  a study investigating the storage stability of thiabendazole and 5-hydroxythiabendazole in fat 
(to be addressed under Regulation (EU) No 1141/2010); 
  a  detailed  evaluation  report  on  the  available  feeding  studies,  including  details  on  the 
analytical methods used and their capacity to analyse conjugates of 5-hydroxythiabendazole; 
  a livestock feeding study investigating all compounds included in the residue definition for 
risk assessment (depending on the outcome of other data gaps listed above). 
It is highlighted, however, that some of the MRLs derived result from a CXL, while other GAPs 
reported by the RMS were not fully supported by data. EFSA therefore identified the following data 
gap which is not expected to impact on the validity of the MRLs derived but which might have an 
impact on national authorisations: 
  clarifications regarding the equivalence of the different post-harvest treatments authorised on 
citrus fruits in Europe; 
If the above reported data gaps are not addressed in the future, Member States are recommended to 
withdraw or modify the relevant authorisations at national level. 
Minor deficiencies were also identified in the assessment but these deficiencies are not expected to 
impact either on the validity of the MRLs derived or on the national authorisations. The following 
data are therefore considered desirable but not essential: 
  4 residue trials on witloof including data on benzimidazole levels; 
  the storage conditions for all available residues trials; 
  the storage conditions of the samples from the livestock feeding studies. 
SUMMARY TABLE 
Code 
number 
Commodity  Existing 
EU MRL 
(mg/kg) 
Existing 
CXL 
(mg/kg) 
Outcome of the review 
MRL 
(mg/kg) 
Comment 
Enforcement residue definition: thiabendazole 
110000  Citrus fruit  5  7  7  Further consideration needed 
(a)   
130010  Apples  5  3  3  Further consideration needed 
(b) 
130020  Pears  5  3  3  Further consideration needed 
(b) 
130030  Quinces  0.05*  3  3  Further consideration needed 
(c)   Review of the existing MRLs for thiabendazole 
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Code 
number 
Commodity  Existing 
EU MRL 
(mg/kg) 
Existing 
CXL 
(mg/kg) 
Outcome of the review 
MRL 
(mg/kg) 
Comment 
130040  Medlar  0.05*  3  3  Further consideration needed 
(c)  
130050  Loquat  0.05*  3  3  Further consideration needed 
(c)  
163010  Avocados  15  15  20  Further consideration needed 
(b) 
163020  Bananas  5  5  5  Further consideration needed 
(d) 
163030  Mangoes  5  5  20  Further consideration needed 
(b) 
163040  Papaya  10  10  10  Further consideration needed 
(b)  
211000  Potatoes  15  15  15  Further consideration needed 
(b)  
255000  Witloof  1  0.05*  0.05  Further consideration needed 
(b)  
280010  Cultivated fungi  10  60  60  Further consideration needed 
(c)  
-  Other products of plant 
origin 
App. C.1  App. C.2  -  Further consideration needed 
(e) 
Enforcement residue definition: sum of thiabendazole and 5-hydroxythiabendazole, expressed as 
thiabendazole 
1011010  Swine muscle  0.1  -  0.02  Further consideration needed 
(f) 
1011020  Swine fat (free of lean 
meat) 
0.1  -  0.03  Further consideration needed 
(f) 
1011030  Swine liver  0.1  -  0.15  Further consideration needed 
(f) 
1011040  Swine kidney  0.1  -  0.3  Further consideration needed 
(f) 
1012010  Bovine muscle  -  0.1  0.1  Further consideration needed 
(a)  
1012020  Bovine fat  -  0.1  0.1  Further consideration needed 
(a) 
1012030  Bovine liver  -  0.3  0.3  Further consideration needed 
(a)  
1012040  Bovine kidney  -  1  1  Further consideration needed 
(a)  
1013010  Sheep muscle  -  -  0.1  Further consideration needed 
(g) 
1013020  Sheep fat  -  -  0.1  Further consideration needed 
(g) 
1013030  Sheep liver  -  -  0.3  Further consideration needed 
(g) 
1013040  Sheep kidney  -  -  1  Further consideration needed 
(g) 
1014010  Goat muscle  -  -  0.1  Further consideration needed 
(g) 
1014020  Goat fat  -  -  0.1  Further consideration needed 
(g) 
1014030  Goat liver  -  -  0.3  Further consideration needed 
(g) 
1014040  Goat kidney  -  -  1  Further consideration needed 
(g) 
1016010  Poultry muscle  0.1  0.05  0.05  Further consideration needed 
(a)  
1016020  Poultry fat  0.1  0.05  0.05  Further consideration needed 
(a) 
1016030  Poultry liver  0.1  -  0.07  Further consideration needed 
(f) 
1030000  Birds' eggs  0.1*  0.1  0.1  Further consideration needed 
(a)  
-  Other products of animal 
origin (except milk) 
App. C.1  App. C.2  -  Further consideration needed 
(e) 
Enforcement residue definition: sum of thiabendazole, 5-hydroxythiabendazole and its sulphate conjugate, Review of the existing MRLs for thiabendazole 
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Code 
number 
Commodity  Existing 
EU MRL 
(mg/kg) 
Existing 
CXL 
(mg/kg) 
Outcome of the review 
MRL 
(mg/kg) 
Comment 
expressed as thiabendazole 
1020010  Cattle milk  -  0.2  0.2  Further consideration needed 
(a)  
1020020  Sheep milk  -  -  0.2  Further consideration needed 
(g) 
1020030  Goat milk  -  -  0.2  Further consideration needed 
(g) 
(*):  Indicates that the MRL is set at the limit of analytical quantification. 
(a):  MRL is derived from the existing CXL, which is not sufficiently supported by data but for which no risk to consumers 
is identified (assuming the existing residue definition); GAP evaluated at EU level, which is also not fully supported by 
data, would lead to a lower tentative MRL (combination E-V in Appendix D). 
(b):  Tentative MRL is derived from a GAP evaluated at EU level, which is not fully supported by data but for which no risk 
to consumers could be identified; existing CXL is covered by the tentative MRL (combination E-III in Appendix D). 
(c):  MRL is derived from the existing CXL, which is not sufficiently supported by data but for which no risk to consumers 
is  identified  (assuming  the  existing  residue  definition);  there  are  no  relevant  authorisations  or  import  tolerances 
reported at EU level (combination A-V in Appendix D). 
(d):  GAP evaluated at EU level is not supported by data but no risk to consumers could be identified for the existing EU 
MRL; existing CXL is covered by the existing EU MRL (combination C-III in Appendix D). 
(e):  There are no relevant authorisations or import tolerances reported at EU level; no CXL is available. Either the specific 
LOQ or the default MRL of 0.01 mg/kg may be considered (combination A-I in Appendix D). 
(f):  Tentative MRL is derived from a GAP evaluated at EU level, which is not fully supported by data but for which no risk 
to consumers could be identified (assuming the existing residue definition); no CXL is available (combination E-I in 
Appendix D). 
(g):  MRL is derived from the existing CXL for bovine, which is not sufficiently supported by data but which is considered 
applicable to other ruminants as well and for which no risk to consumers is identified (assuming the existing residue 
definition); GAP evaluated at EU level, which is also not fully supported by data, would lead to a lower tentative MRL 
(combination E-V in Appendix D). 
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APPENDIX A – GOOD AGRICULTURAL PRACTICES (GAPS) 
Conc. Unit
From 
BBCH
Until 
BBCH
Min. Max. Min. Max.
Grapefruit Citrus paradisi  NEU/SEU Indoor ES, FR, PT
Penicillium spp., 
Phomopsis spp., 
Botrytis spp., Diplodia 
spp., Rhizopus spp.
SC 500.0 g/L Post-harvest - spraying 99 1 1.80 3.00 g a.i./ton n.a.
On-line water or wax spraying: 1.8-3 
g a.s./T citrus
Oranges Citrus sinensis  NEU/SEU Indoor ES, FR, PT
Penicillium spp., 
Phomopsis spp., 
Botrytis spp., Diplodia 
spp., Rhizopus spp.
SC 500.0 g/L Post-harvest treatment - drenching 99 1 24.00 40.00 g a.i./ton n.a.
Drenching/dipping on oranges: 24-
40 g a.s./T fruits or On-line water or 
wax spraying: 1.8-3 g a.s./T citrus 
Lemons Citrus limon  NEU/SEU Indoor ES, FR, PT
Penicillium spp., 
Phomopsis spp., 
Botrytis spp., Diplodia 
spp., Rhizopus spp.
SC 500.0 g/L Post-harvest - spraying 99 1 1.80 3.00 g a.i./ton n.a.
On-line water or wax spraying: 1.8-3 
g a.s./T citrus
Limes Citrus aurantifolia NEU/SEU Indoor ES, FR, PT
Penicillium spp., 
Phomopsis spp., 
Botrytis spp., Diplodia 
spp., Rhizopus spp.
SC 500.0 g/L Post-harvest - spraying 99 1 1.80 3.00 g a.i./ton n.a.
On-line water or wax spraying: 1.8-3 
g a.s./T citrus
Mandarins Citrus reticulata  NEU/SEU Indoor ES, FR, PT
Penicillium spp., 
Phomopsis spp., 
Botrytis spp., Diplodia 
spp., Rhizopus spp.
SC 500.0 g/L Post-harvest treatment - drenching 99 1 30.00 50.00 g a.i./ton n.a.
Drenching/dipping on mandarins: 30-
50 g a.s./T fruits  or On-line water or 
wax spraying: 1.8-3 g a.s./T citrus 
Apples Malus domesticus  NEU/SEU Indoor
BE, ES, FR, IT, 
PT
Penicillium spp., 
Botrytis spp., 
Gloeosporium spp., 
Rhizopus spp.
SC 500.0 g/L Post-harvest treatment - drenching 99 1 33.00 48.00 g a.i./ton n.a.
Pears Pyrus communis  NEU/SEU Indoor
BE, ES, FR, IT, 
PT
Penicillium spp., 
Botrytis spp., 
Gloeosporium spp., 
Rhizopus spp.
SC 500.0 g/L Post-harvest treatment - drenching 99 1 33.00 48.00 g a.i./ton n.a.
Bananas Musa x paradisica NEU/SEU Indoor ES, FR, PT
Fusarium spp., 
Colletotrichum musae, 
Verticillium theobromae, 
Thielaviopsis paradoxa, 
Ceratocystis paradoxa, 
Botryodiplodia 
theobromae, 
Deightoniella torulosa, 
Nigrospora spp.
SC 500.0 g/L Post-harvest treatment - dipping 99 1 54.00 g a.i./ton n.a.
Application methods:
- Drenching/dipping: 54 g a.i./T 
bananas or 
Spraying: 7 g a.i./T bananas
Potatoes
Tuber form Solanum 
Spp
NEU/SEU Indoor
AT, BE, DE, FR, 
IE, IT, LU, NL, UK
Fusarium spp., 
Rhizoctonia solani, 
Phoma exigua, 
Helminthosporium 
solani, Oospora 
pustulans, Polysctalum 
pustulans
SC 500.0 g/L Post-harvest - spraying 99 1 40.00 g a.i./ton n.a.
Application methods:
- Spinning disc equipment: 0,08 
water L/tonne of potatoes
- ultra low volume spraying: 2 water 
L/tonne of potatoes
Witloof
Cichorium intybus. var. 
Foliosum 
NEU/SEU Indoor BE, FR Phoma exigua SC 500.0 g/L
Local treatment - general (see also 
comment field)
99 1 10.00 36.00 g a.i./ton n.a.
Application methods:
- Drenching/dipping: 10 g a.i./T 
witloof or 
- Spraying: 36 g a.i./T witloof
Cultivated fungi Not specified NEU/SEU Indoor IT
Aphelenchoides 
composticola, 
Mycogone perniciosa, 
Dactylum spp., 
Tricoderma spp., 
Verticillium fungicola
SC 500.0 g/L Post-harvest - spraying 99 1 125.00 g a.i./hL n.a.
Application methods:
Irrigation or spraying
Application rates:
Early infections (125 g a.i./hl; 1 
application) or 
Late infections (62,5 g a.i./hl + 50 g 
a.i./hl + 50 g a.i./hl; 3 applications)
Chicory roots Cichorium intybus NEU/SEU Indoor BE, FR Phoma spp. SC 500.0 g/L Post-harvest - spraying 99 1 40.00 g a.i./ton n.a.
Application method:
- Spraying: 2 g a.i./l
EFSA:This GAP as a post-harvest 
treatment on chicory roots for 
production of inuline and not for 
production of leaves for consumption 
should be disregarded as not 
representative of the practical uses.
Growth stage Number Interval (days)
Min. rate Max. rate Rate Unit
Formulation Application Application rate PHI  or 
wiaiting 
period 
(days)
Comments (max. 250 charachters)
Common name Scientific name Type
Content
Method
Critical Indoor GAPs for Northern and Southern Europe (incl. post-harvest treatments)
Crop
Region
Outdoor/ 
Indoor
Member state or 
Country
Pests controlled
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Conc. Unit
From 
BBCH
Until 
BBCH
Min. Max. Min. Max.
Avocados Persea americana non-EU Indoor Kenya SC 450.0 g/L
Post-harvest treatment - general 
(see also comment field)
99 1 110.00 340.00 g a.i./hL
Application method:
dipping (30 sec) or spraying
Mangoes Mangifera indica non-EU Indoor Kenya SC 450.0 g/L
Post-harvest treatment - general 
(see also comment field)
99 1 110.00 340.00 g a.i./hL
Application method:
dipping (30 sec) or spraying
Papaya Carica papaya non-EU Indoor USA SC 450.0 g/L
Post-harvest treatment - general 
(see also comment field)
99 1 200.00 g a.i./hL
Application method:
dipping (30 sec) or spraying
Max. rate Rate Unit
Comments (max. 250 charachters)
Common name Scientific name Type
Content
Method
Growth stage Number Interval (days)
Min. rate
Critical GAPs for Import Tolerances (non-European indoor, outdoor or post-harvest treatments)
Crop
Region
Outdoor/ 
Indoor
Member state or 
Country
Pests controlled
Formulation Application Application rate PHI  or 
wiaiting 
period 
(days)
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APPENDIX B – PESTICIDE RESIDUES INTAKE MODEL (PRIMO) 
Appendix B.1 – EU scenario including all EU MRL proposals resulting from the GAPs reported by the RMS 
Appendix B.2 – EU/Codex scenario including demonstrated safe EU MRL proposals and all CXLs Review of the existing MRLs for thiabendazole 
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APPENDIX B.1 – EU SCENARIO INCLUDING ALL EU MRL PROPOSALS RESULTING FROM THE GAPS REPORTED BY THE RMS 
Status of the active substance: Included Code no.
LOQ (mg/kg bw): proposed LOQ:
ADI (mg/kg bw/day): 0,1 ARfD (mg/kg bw): n.n.
Source of ADI: COM Source of ARfD: COM
Year of evaluation: 2001 Year of evaluation: 2001
6 53
No of diets exceeding ADI: ---
Highest calculated 
TMDI values in % 
of ADI  MS Diet
Highest contributor 
to MS diet 
(in % of ADI)
2nd contributor to 
MS diet 
(in % of ADI)
3rd contributor to 
MS diet 
(in % of ADI)
Commodity / 
group of commodities
pTMRLs at 
LOQ
(in % of ADI)
52,7 NL child 31,8 10,8 8,5 Bananas
43,7 DE child 20,5 13,8 7,7 Bananas
39,4 FR toddler 27,4 6,5 4,5 Apples
34,3 SE  general population 90th percentile 22,5 9,0 1,8 Apples
32,9 PT General population 28,8 1,8 1,7 Bananas
31,1 FR infant 22,3 4,3 3,6 Bananas
28,5 UK Infant  17,6 7,3 2,7 Apples
27,8 UK Toddler 18,9 5,4 2,9 Apples
25,2 WHO regional European diet  21,7 1,9 1,1 Apples
24,5 WHO cluster diet E 20,7 1,8 1,4 Apples
24,3 DK child 13,1 5,7 3,9 Apples
23,9 WHO cluster diet D 21,9 1,1 0,6 Bananas
23,4 PL  general population 18,6 3,5 0,9 Bananas
22,7 WHO Cluster diet F  18,4 2,8 1,1 Apples
21,0 LT adult 17,1 3,2 0,3 Bananas
20,4 IE adult 12,4 3,9 1,4 Apples
19,0 NL general 14,8 2,0 1,6 Bananas
18,7 WHO Cluster diet B  14,5 1,7 1,6 Bananas
18,0 ES child 9,9 5,1 1,9 Apples
11,6 DK adult 7,9 1,9 1,3 Apples
10,6 UK vegetarian 7,4 1,9 1,0 Apples
10,2 UK Adult  7,5 1,8 0,7 Apples
9,6 IT kids/toddler 4,8 2,7 1,5 Apples
8,9 ES adult 5,0 1,8 1,3 Apples
8,7 FI  adult 6,6 1,3 0,7 Apples
8,5 FR all population 6,1 1,2 0,8 Apples
6,0 IT adult 3,2 1,3 1,0 Bananas
Bananas
Bananas
Potatoes Apples
Bananas
Bananas
Bananas
Bananas
Bananas
Bananas
Apples
Bananas
Apples
Apples
Bananas
Bananas
Bananas
Bananas
Bananas
Bananas
Apples
Apples
Potatoes
Bananas
Bananas
Apples
Apples
Commodity / 
group of commodities
Commodity / 
group of commodities
Potatoes
Apples
Thiabendazole
Toxicological end points
                     TMDI (range) in % of ADI
                        minimum - maximum
Chronic risk assessment - refined calculations
Conclusion:
The estimated Theoretical Maximum Daily Intakes (TMDI), based on pTMRLs were below the ADI. 
A long-term intake of residues of  Thiabendazole is unlikely to present a public health concern.
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Apples
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
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APPENDIX B.2 – EU/CODEX SCENARIO INCLUDING DEMONSTRATED SAFE EU MRL PROPOSALS AND ALL CXLS 
Status of the active substance: Included Code no.
LOQ (mg/kg bw): proposed LOQ:
ADI (mg/kg bw/day): 0,1 ARfD (mg/kg bw): n.n.
Source of ADI: COM Source of ARfD: COM
Year of evaluation: 2001 Year of evaluation: 2001
8 61
No of diets exceeding ADI: ---
Highest calculated 
TMDI values in % 
of ADI  MS Diet
Highest contributor 
to MS diet 
(in % of ADI)
2nd contributor to 
MS diet 
(in % of ADI)
3rd contributor to 
MS diet 
(in % of ADI)
Commodity / 
group of commodities
pTMRLs at 
LOQ
(in % of ADI)
60,9 NL child 31,8 10,8 8,5 Bananas
49,1 DE child 20,5 13,8 7,7 Bananas
44,4 FR toddler 27,4 6,5 4,8 Milk and cream, 
36,2 SE  general population 90th percentile 22,5 9,0 1,8 Apples
34,2 FR infant 22,3 4,3 3,6 Bananas
33,6 UK Infant  17,6 7,3 4,6 Milk and cream, 
33,1 PT General population 28,8 1,8 1,7 Bananas
32,7 UK Toddler 18,9 5,4 2,9 Apples
28,8 IE adult 12,4 7,3 3,9 Bananas
28,1 WHO regional European diet  21,7 2,1 1,9 Bananas
27,9 WHO cluster diet E 20,7 2,7 1,8 Bananas
27,4 PL  general population 18,6 3,9 3,5 Apples
27,3 DK child 13,1 5,7 3,9 Apples
24,8 WHO cluster diet D 21,9 1,1 0,6 Milk and cream, 
24,3 WHO Cluster diet F  18,4 2,8 1,1 Apples
22,7 NL general 14,8 2,5 2,0 Apples
21,5 LT adult 17,1 3,2 0,5 Milk and cream, 
20,8 ES child 9,9 5,1 1,9 Apples
20,4 WHO Cluster diet B  14,5 1,7 1,6 Bananas
15,1 UK vegetarian 7,4 3,9 1,9 Bananas
13,7 DK adult 7,9 1,9 1,4 Cultivated fungi
12,7 UK Adult  7,5 1,9 1,8 Bananas
12,0 ES adult 5,0 2,1 1,8 Bananas
11,1 IT kids/toddler 4,8 2,7 1,5 Apples
9,6 FI  adult 6,6 1,3 0,7 Apples
9,0 FR all population 6,1 1,2 0,8 Apples
7,7 IT adult 3,2 1,6 1,3 Apples
Cultivated fungi
Bananas
Potatoes Cultivated fungi
Bananas
Cultivated fungi
Cultivated fungi
Bananas
Bananas
Apples
Bananas
Cultivated fungi
Apples
Bananas
Apples
Apples
Bananas
Cultivated fungi
Cultivated fungi
Cultivated fungi
Cultivated fungi
Apples
Potatoes
Bananas
Bananas
Apples
Bananas
Commodity / 
group of commodities
Commodity / 
group of commodities
Potatoes
Apples
Thiabendazole
Toxicological end points
                     TMDI (range) in % of ADI
                        minimum - maximum
Chronic risk assessment - refined calculations
Conclusion:
The estimated Theoretical Maximum Daily Intakes (TMDI), based on pTMRLs were below the ADI. 
A long-term intake of residues of  Thiabendazole is unlikely to present a public health concern.
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Bananas
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
Potatoes
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APPENDIX C – EXISTING EU MAXIMUM RESIDUE LIMITS (MRLS), CODEX LIMITS (CXLS) AND VETERINARY MRLS 
Appendix C.1 – Existing EU MRLs 
Appendix C.2 – Existing CXLs 
Appendix C.3 – Veterinary MRLs Review of the existing MRLs for thiabendazole 
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APPENDIX C.1 – EXISTING EU MRLS 
(Pesticides - Web Version - EU MRLs (File created on 12/06/2014 13:37) 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
Thiabendazole 
(R) 
100000  1. FRUIT FRESH OR 
FROZEN; NUTS    
110000  (i) Citrus fruit  5 
110010  Grapefruit (Shaddocks, 
pomelos, sweeties, tangelo, ugli 
and other hybrids)  5 
110020  Oranges (Bergamot, bitter 
orange, chinotto and other 
hybrids)  5 
110030  Lemons (Citron, lemon )  5 
110040  Limes  5 
110050  Mandarins (Clementine, 
tangerine and other hybrids)  5 
110990  Others  5 
120000  (ii) Tree nuts (shelled or 
unshelled)  0.1* 
120010  Almonds  0.1* 
120020  Brazil nuts  0.1* 
120030  Cashew nuts  0.1* 
120040  Chestnuts  0.1* 
120050  Coconuts  0.1* 
120060  Hazelnuts (Filbert)  0.1* 
120070  Macadamia  0.1* 
120080  Pecans  0.1* 
120090  Pine nuts  0.1* 
120100  Pistachios  0.1* 
120110  Walnuts  0.1* 
120990  Others  0.1* 
130000  (iii) Pome fruit    
130010  Apples (Crab apple)  5 
130020  Pears (Oriental pear)  5 
130030  Quinces  0.05* 
130040  Medlar  0.05* 
130050  Loquat  0.05* 
130990  Others  0.05* 
140000  (iv) Stone fruit  0.05* 
140010  Apricots  0.05* 
140020  Cherries (sweet cherries, sour 
cherries)  0.05* 
140030  Peaches (Nectarines and 
similar hybrids)  0.05* 
140040  Plums (Damson, greengage,  0.05* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
Thiabendazole 
(R) 
mirabelle) 
140990  Others  0.05* 
150000  (v) Berries & small fruit  0.05* 
151000  (a) Table and wine grapes  0.05* 
151010  Table grapes  0.05* 
151020  Wine grapes  0.05* 
152000  (b) Strawberries  0.05* 
153000  (c) Cane fruit  0.05* 
153010  Blackberries  0.05* 
153020  Dewberries (Loganberries, 
Boysenberries, and 
cloudberries)  0.05* 
153030  Raspberries (Wineberries )  0.05* 
153990  Others  0.05* 
154000  (d) Other small fruit & berries  0.05* 
154010  Blueberries (Bilberries 
cowberries (red bilberries))  0.05* 
154020  Cranberries  0.05* 
154030  Currants (red, black and white)  0.05* 
154040  Gooseberries (Including 
hybrids with other ribes 
species)  0.05* 
154050  Rose hips  0.05* 
154060  Mulberries (arbutus berry)  0.05* 
154070  Azarole (mediteranean medlar)  0.05* 
154080  Elderberries (Black chokeberry 
(appleberry), mountain ash, 
azarole, buckthorn (sea 
sallowthorn), hawthorn, service 
berries, and other treeberries)  0.05* 
154990  Others  0.05* 
160000  (vi) Miscellaneous fruit    
161000  (a) Edible peel  0.05* 
161010  Dates  0.05* 
161020  Figs  0.05* 
161030  Table olives  0.05* 
161040  Kumquats (Marumi kumquats, 
nagami kumquats)  0.05* 
161050  Carambola (Bilimbi)  0.05* 
161060  Persimmon  0.05* 
161070  Jambolan (java plum) (Java 
apple (water apple), pomerac, 
rose apple, Brazilean cherry  0.05* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
Thiabendazole 
(R) 
(grumichama), Surinam cherry) 
161990  Others  0.05* 
162000  (b) Inedible peel, small  0.05* 
162010  Kiwi  0.05* 
162020  Lychee (Litchi) (Pulasan, 
rambutan (hairy litchi))  0.05* 
162030  Passion fruit  0.05* 
162040  Prickly pear (cactus fruit)  0.05* 
162050  Star apple  0.05* 
162060  American persimmon (Virginia 
kaki) (Black sapote, white 
sapote, green sapote, canistel 
(yellow sapote), and mammey 
sapote)  0.05* 
162990  Others  0.05* 
163000  (c) Inedible peel, large    
163010  Avocados  15 
163020  Bananas (Dwarf banana, 
plantain, apple banana)  5 
163030  Mangoes  5 
163040  Papaya  10 
163050  Pomegranate  0.05* 
163060  Cherimoya (Custard apple, 
sugar apple (sweetsop) , llama 
and other medium sized 
Annonaceae)  0.05* 
163070  Guava  0.05* 
163080  Pineapples  0.05* 
163090  Bread fruit (Jackfruit)  0.05* 
163100  Durian  0.05* 
163110  Soursop (guanabana)  0.05* 
163990  Others  0.05* 
200000  2. VEGETABLES FRESH 
OR FROZEN    
210000  (i) Root and tuber vegetables    
211000  (a) Potatoes  15 
212000  (b) Tropical root and tuber 
vegetables    
212010  Cassava (Dasheen, eddoe 
(Japanese taro), tannia)  15 
212020  Sweet potatoes  15 
212030  Yams (Potato bean (yam 
bean), Mexican yam bean)  15 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
Thiabendazole 
(R) 
212040  Arrowroot  0.05* 
212990  Others  0.05* 
213000  (c) Other root and tuber 
vegetables except sugar beet  0.05* 
213010  Beetroot  0.05* 
213020  Carrots  0.05* 
213030  Celeriac  0.05* 
213040  Horseradish  0.05* 
213050  Jerusalem artichokes  0.05* 
213060  Parsnips  0.05* 
213070  Parsley root  0.05* 
213080  Radishes (Black radish, 
Japanese radish, small radish 
and similar varieties)  0.05* 
213090  Salsify (Scorzonera, Spanish 
salsify (Spanish oysterplant))  0.05* 
213100  Swedes  0.05* 
213110  Turnips  0.05* 
213990  Others  0.05* 
220000  (ii) Bulb vegetables  0.05* 
220010  Garlic  0.05* 
220020  Onions (Silverskin onions)  0.05* 
220030  Shallots  0.05* 
220040  Spring onions (Welsh onion 
and similar varieties)  0.05* 
220990  Others  0.05* 
230000  (iii) Fruiting vegetables  0.05* 
231000  (a) Solanacea  0.05* 
231010  Tomatoes (Cherry tomatoes, )  0.05* 
231020  Peppers (Chilli peppers)  0.05* 
231030  Aubergines (egg plants) 
(Pepino)  0.05* 
231040  Okra, lady’s fingers  0.05* 
231990  Others  0.05* 
232000  (b) Cucurbits - edible peel  0.05* 
232010  Cucumbers  0.05* 
232020  Gherkins  0.05* 
232030  Courgettes (Summer squash, 
marrow (patisson))  0.05* 
232990  Others  0.05* 
233000  (c) Cucurbits-inedible peel  0.05* 
233010  Melons (Kiwano )  0.05* Review of the existing MRLs for thiabendazole 
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Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
Thiabendazole 
(R) 
233020  Pumpkins (Winter squash)  0.05* 
233030  Watermelons  0.05* 
233990  Others  0.05* 
234000  (d) Sweet corn  0.05* 
239000  (e) Other fruiting vegetables  0.05* 
240000  (iv) Brassica vegetables    
241000  (a) Flowering brassica    
241010  Broccoli (Calabrese, Chinese 
broccoli, Broccoli raab)  5 
241020  Cauliflower  0.05* 
241990  Others  0.05* 
242000  (b) Head brassica  0.05* 
242010  Brussels sprouts  0.05* 
242020  Head cabbage (Pointed head 
cabbage, red cabbage, savoy 
cabbage, white cabbage)  0.05* 
242990  Others  0.05* 
243000  (c) Leafy brassica  0.05* 
243010  Chinese cabbage (Indian 
(Chinese) mustard, pak choi, 
Chinese flat cabbage (tai goo 
choi), peking cabbage (pe-tsai), 
cow cabbage)  0.05* 
243020  Kale (Borecole (curly kale), 
collards)  0.05* 
243990  Others  0.05* 
244000  (d) Kohlrabi  0.05* 
250000  (v) Leaf vegetables & fresh 
herbs    
251000  (a) Lettuce and other salad 
plants including Brassicacea  0.05* 
251010  Lamb´s lettuce (Italian 
cornsalad)  0.05* 
251020  Lettuce (Head lettuce, lollo 
rosso (cutting lettuce), iceberg 
lettuce, romaine (cos) lettuce)  0.05* 
251030  Scarole (broad-leaf endive) 
(Wild chicory, red-leaved 
chicory, radicchio, curld leave 
endive, sugar loaf)  0.05* 
251040  Cress  0.05* 
251050  Land cress  0.05* 
251060  Rocket, Rucola (Wild rocket)  0.05* 
251070  Red mustard  0.05* 
251080  Leaves and sprouts of Brassica 
spp (Mizuna)  0.05* 
251990  Others  0.05* 
252000  (b) Spinach & similar (leaves)  0.05* 
252010  Spinach (New Zealand  0.05* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
Thiabendazole 
(R) 
spinach, turnip greens (turnip 
tops)) 
252020  Purslane (Winter purslane 
(miner’s lettuce), garden 
purslane, common purslane, 
sorrel, glassworth)  0.05* 
252030  Beet leaves (chard) (Leaves of 
beetroot)  0.05* 
252990  Others  0.05* 
253000  (c) Vine leaves (grape leaves)  0.05* 
254000  (d) Water cress  0.05* 
255000  (e) Witloof  1 
256000  (f) Herbs  0.05* 
256010  Chervil  0.05* 
256020  Chives  0.05* 
256030  Celery leaves (fennel leaves , 
Coriander leaves, dill leaves, 
Caraway leaves, lovage, 
angelica, sweet cisely and other 
Apiacea)  0.05* 
256040  Parsley  0.05* 
256050  Sage (Winter savory, summer 
savory, )  0.05* 
256060  Rosemary  0.05* 
256070  Thyme ( marjoram, oregano)  0.05* 
256080  Basil (Balm leaves, mint, 
peppermint)  0.05* 
256090  Bay leaves (laurel)  0.05* 
256100  Tarragon (Hyssop)  0.05* 
256990  Others  0.05* 
260000  (vi) Legume vegetables (fresh)  0.05* 
260010  Beans (with pods) (Green bean 
(french beans, snap beans), 
scarlet runner bean, slicing 
bean, yardlong beans)  0.05* 
260020  Beans (without pods) (Broad 
beans, Flageolets, jack bean, 
lima bean, cowpea)  0.05* 
260030  Peas (with pods) (Mangetout 
(sugar peas))  0.05* 
260040  Peas (without pods) (Garden 
pea, green pea, chickpea)  0.05* 
260050  Lentils  0.05* 
260990  Others  0.05* 
270000  (vii) Stem vegetables (fresh)  0.05* 
270010  Asparagus  0.05* 
270020  Cardoons  0.05* 
270030  Celery  0.05* 
270040  Fennel  0.05* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
Thiabendazole 
(R) 
270050  Globe artichokes  0.05* 
270060  Leek  0.05* 
270070  Rhubarb  0.05* 
270080  Bamboo shoots  0.05* 
270090  Palm hearts  0.05* 
270990  Others  0.05* 
280000  (viii) Fungi    
280010  Cultivated (Common 
mushroom, Oyster mushroom, 
Shi-take)  10 
280020  Wild (Chanterelle, Truffle, 
Morel ,)  0.05* 
280990  Others  0.05* 
290000  (ix) Sea weeds  0.05* 
300000  3. PULSES, DRY  0.05* 
300010  Beans (Broad beans, navy 
beans, flageolets, jack beans, 
lima beans, field beans, 
cowpeas)  0.05* 
300020  Lentils  0.05* 
300030  Peas (Chickpeas, field peas, 
chickling vetch)  0.05* 
300040  Lupins  0.05* 
300990  Others  0.05* 
400000  4. OILSEEDS AND 
OILFRUITS  0.05* 
401000  (i) Oilseeds  0.05* 
401010  Linseed  0.05* 
401020  Peanuts  0.05* 
401030  Poppy seed  0.05* 
401040  Sesame seed  0.05* 
401050  Sunflower seed  0.05* 
401060  Rape seed (Bird rapeseed, 
turnip rape)  0.05* 
401070  Soya bean  0.05* 
401080  Mustard seed  0.05* 
401090  Cotton seed  0.05* 
401100  Pumpkin seeds  0.05* 
401110  Safflower  0.05* 
401120  Borage  0.05* 
401130  Gold of pleasure  0.05* 
401140  Hempseed  0.05* 
401150  Castor bean  0.05* 
401990  Others  0.05* 
402000  (ii) Oilfruits  0.05* 
402010  Olives for oil production  0.05* 
402020  Palm nuts (palmoil kernels)  0.05* 
402030  Palmfruit  0.05* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
Thiabendazole 
(R) 
402040  Kapok  0.05* 
402990  Others  0.05* 
500000  5. CEREALS  0.05* 
500010  Barley  0.05* 
500020  Buckwheat  0.05* 
500030  Maize  0.05* 
500040  Millet (Foxtail millet, teff)  0.05* 
500050  Oats  0.05* 
500060  Rice  0.05* 
500070  Rye  0.05* 
500080  Sorghum  0.05* 
500090  Wheat (Spelt Triticale)  0.05* 
500990  Others  0.05* 
600000  6. TEA, COFFEE, HERBAL 
INFUSIONS AND COCOA  0.1* 
610000  (i) Tea (dried leaves and stalks, 
fermented or otherwise of 
Camellia sinensis)  0.1* 
620000  (ii) Coffee beans  0.1* 
630000  (iii) Herbal infusions (dried)  0.1* 
631000  (a) Flowers  0.1* 
631010  Camomille flowers  0.1* 
631020  Hybiscus flowers  0.1* 
631030  Rose petals  0.1* 
631040  Jasmine flowers  0.1* 
631050  Lime (linden)  0.1* 
631990  Others  0.1* 
632000  (b) Leaves  0.1* 
632010  Strawberry leaves  0.1* 
632020  Rooibos leaves  0.1* 
632030  Maté  0.1* 
632990  Others  0.1* 
633000  (c) Roots  0.1* 
633010  Valerian root  0.1* 
633020  Ginseng root  0.1* 
633990  Others  0.1* 
639000  (d) Other herbal infusions  0.1* 
640000  (iv) Cocoa (fermented beans)  0.1* 
650000  (v) Carob (st johns bread)  0.1* 
700000  7. HOPS (dried) , including 
hop pellets and unconcentrated 
powder  0.1* 
800000  8. SPICES  0.1* 
810000  (i) Seeds  0.1* 
810010  Anise  0.1* 
810020  Black caraway  0.1* 
810030  Celery seed (Lovage seed)  0.1* 
810040  Coriander seed  0.1* Review of the existing MRLs for thiabendazole 
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Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
Thiabendazole 
(R) 
810050  Cumin seed  0.1* 
810060  Dill seed  0.1* 
810070  Fennel seed  0.1* 
810080  Fenugreek  0.1* 
810090  Nutmeg  0.1* 
810990  Others  0.1* 
820000  (ii) Fruits and berries  0.1* 
820010  Allspice  0.1* 
820020  Anise pepper (Japan pepper)  0.1* 
820030  Caraway  0.1* 
820040  Cardamom  0.1* 
820050  Juniper berries  0.1* 
820060  Pepper, black and white (Long 
pepper, pink pepper)  0.1* 
820070  Vanilla pods  0.1* 
820080  Tamarind  0.1* 
820990  Others  0.1* 
830000  (iii) Bark  0.1* 
830010  Cinnamon (Cassia )  0.1* 
830990  Others  0.1* 
840000  (iv) Roots or rhizome  0.1* 
840010  Liquorice  0.1* 
840020  Ginger  0.1* 
840030  Turmeric (Curcuma)  0.1* 
840040  Horseradish  0.1* 
840990  Others  0.1* 
850000  (v) Buds  0.1* 
850010  Cloves  0.1* 
850020  Capers  0.1* 
850990  Others  0.1* 
860000  (vi) Flower stigma  0.1* 
860010  Saffron  0.1* 
860990  Others  0.1* 
870000  (vii) Aril  0.1* 
870010  Mace  0.1* 
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
Thiabendazole 
(R) 
870990  Others  0.1* 
900000  9. SUGAR PLANTS  0.05* 
900010  Sugar beet (root)  0.05* 
900020  Sugar cane  0.05* 
900030  Chicory roots  0.05* 
900990  Others  0.05* 
1000000  10. PRODUCTS OF 
ANIMAL ORIGIN-
TERRESTRIAL ANIMALS    
1010000  (i) Meat, preparations of meat, 
offals, blood, animal fats fresh 
chilled or frozen, salted, in 
brine, dried or smoked or 
processed as flours or meals 
other processed products such 
as sausages and food 
preparations based on these    
1011000  (a) Swine  0.1 
1011010  Meat  0.1 
1011020  Fat free of lean meat  0.1 
1011030  Liver  0.1 
1011040  Kidney  0.1 
1011050  Edible offal  0.1 
1011990  Others  0.1 
1012000  (b) Bovine    
1012010  Meat    
1012020  Fat    
1012030  Liver    
1012040  Kidney    
1012050  Edible offal    
1012990  Others    
1013000  (c) Sheep    
1013010  Meat    
1013020  Fat    
1013030  Liver    
1013040  Kidney    
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
Thiabendazole 
(R) 
1013050  Edible offal    
1013990  Others    
1014000  (d) Goat    
1014010  Meat    
1014020  Fat    
1014030  Liver    
1014040  Kidney    
1014050  Edible offal    
1014990  Others    
1015000  (e) Horses, asses, mules or 
hinnies    
1015010  Meat    
1015020  Fat    
1015030  Liver    
1015040  Kidney    
1015050  Edible offal    
1015990  Others    
1016000  (f) Poultry -chicken, geese, 
duck, turkey and Guinea fowl-, 
ostrich, pigeon  0.1 
1016010  Meat  0.1 
1016020  Fat  0.1 
1016030  Liver  0.1 
1016040  Kidney  0.1 
1016050  Edible offal  0.1 
1016990  Others  0.1 
1017000  (g) Other farm animals (Rabbit, 
Kangaroo)    
1017010  Meat    
1017020  Fat    
1017030  Liver    
1017040  Kidney    
1017050  Edible offal    
1017990  Others    
1020000  (ii) Milk and cream, not 
concentrated, nor containing    
Code 
number 
Groups and examples of 
individual products to which 
the MRLs apply (a) 
Thiabendazole 
(R) 
added sugar or sweetening 
matter, butter and other fats 
derived from milk, cheese and 
curd 
1020010  Cattle    
1020020  Sheep    
1020030  Goat    
1020040  Horse    
1020990  Others    
1030000  (iii) Birds’ eggs, fresh 
preserved or cooked Shelled 
eggs and egg yolks fresh, dried, 
cooked by steaming or boiling 
in water, moulded, frozen or 
otherwise preserved whether or 
not containing added sugar or 
sweetening matter  0.1* 
1030010  Chicken  0.1* 
1030020  Duck  0.1* 
1030030  Goose  0.1* 
1030040  Quail  0.1* 
1030990  Others  0.1* 
1040000  (iv) Honey (Royal jelly, pollen)    
1050000  (v) Amphibians and reptiles 
(Frog legs, crocodiles)    
1060000  (vi) Snails    
1070000  (vii) Other terrestrial animal 
products    
(*) Indicates lower limit of analytical determination 
(R): The residue definition differs for the following 
combinations pesticide-code number: 
Thiabendazole  -  code  1000000:  Sum  of 
thiabendazole and 5-hydroxythiabendazole 
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APPENDIX C.2 – EXISTING CXLS 
Residue definition Residue definition
STMR (-P) 
(mg/kg)
HR (-P) (mg/kg)
Default 
variability 
factor
Reduced 
variability 
factor
STMR (mg/kg) HR (mg/kg)
Median peeling 
factor
Median 
conversion 
factor
Year
Based on EU 
GAP only?
Other comments
110010 Grapefruit Thiabendazole 7 Thiabendazole 0.045 0.84 3 n.c. 2.7 5.2 0.1 1 2006 No
110020 Oranges Thiabendazole 7 Thiabendazole 0.045 0.84 3 n.c. 2.7 5.2 0.1 1 2006 No
110030 Lemons Thiabendazole 7 Thiabendazole 0.045 0.84 3 n.c. 2.7 5.2 0.1 1 2006 No
110040 Limes Thiabendazole 7 Thiabendazole 0.045 0.84 3 n.c. 2.7 5.2 0.1 1 2006 No
110050 Mandarins Thiabendazole 7 Thiabendazole 0.045 0.84 3 n.c. 2.7 5.2 0.1 1 2006 No
130010 Apples Thiabendazole 3 Thiabendazole 1.7 2 3 n.c. 1.7 2 n.a. 1 2000 Yes
130020 Pears Thiabendazole 3 Thiabendazole 1.7 2 3 n.c. 1.7 2 n.a. 1 2000 Yes
130030 Quinces Thiabendazole 3 Thiabendazole 1.7 2 3 n.c. 1.7 2 n.a. 1 2000 Yes
130040 Medlar Thiabendazole 3 Thiabendazole 1.7 2 3 n.c. 1.7 2 n.a. 1 2000 Yes
130050 Loquat Thiabendazole 3 Thiabendazole 1.7 2 3 n.c. 1.7 2 n.a. 1 2000 Yes
163010 Avocados Thiabendazole 15 Thiabendazole 0.9 1.8 7 n.c. 6.1 12 0.13 1 2000 No All trials were conducted outside of 
the EU according to appropriate 
GAP. Residue levels were based on 
stoneless fruit. JMPR determined a 
peeling factor of 0.13 based on 2 
trials.
163020 Bananas Thiabendazole 5 Thiabendazole 0.029 n.c. 5 n.c. 1.5 3.3 0.02 1 1997 No All trials were conducted outside of 
the EU according to appropriate 
GAP. 
163030 Mangoes Thiabendazole 5 Thiabendazole 2.85 4.6 7 n.c. 2.4 3.8 n.k. 1 2000 No All trials were conducted outside of 
the EU according to appropriate 
GAP. JMPR values were based on 
stoneless fruit. JMPR determined a 
factor of 0.83 to calculate whole 
fruit. No data on pulp residues were 
available.
163040 Papaya Thiabendazole 10 Thiabendazole 3.8 5.1 5 n.c. 3.8 5.1 n.k. 1 2000 No All trials were conducted outside of 
the EU according to appropriate 
GAP. No data on pulp residues 
were available. Values relate to 
whole fruit.
211000 Potatoes Thiabendazole 15 Thiabendazole 5.4 11 7 n.c. 5.4 11 n.a. 1 1997 and 2000 No The majority of trials were 
conducted in the EU according to 
appropriate post-harvest GAPs, 
however a number of USA trials 
were included.
255000 Witloof Thiabendazole 0.05 * Thiabendazole 0.05 n.c. 1 n.c. 0.05 0.05 n.a. 1 1997 Yes All trials conducted in France 
according to appropriate GAP.
280010 Cultivated fungi Thiabendazole 60 Thiabendazole 31 n.c. 1 n.c. 31 52 n.a. 1 1997 No All trials were conducted outside of 
the EU according to appropriate 
GAP.
(*) Indicates the lower limit of analytical quantification.
n.a.: not applicable
n.c.: not considered
n.k.: not known
Trials were conducted in Morocco 
according the appropriate post-
harvest GAP.
All trials were conducted in the EU 
according to appropriate post-
harvest GAPs.
Summary of CXLs for thiabendazole in plant commodities
Commodity 
code
Commodity name
Values adopted by the CCPR
CXL (mg/kg)
Critical values of the JMPR evaluation Comments on the JMPR evaluation Risk assessment values as calculated by EFSA
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Residue definition
Expressed 
as fat?
Residue definition STMR (mg/kg) HR (mg/kg) Year
Based on EU 
GAP only?
Other comments
1012010 Bovine meat Sum of thiabendazole and 5-OH-
thiabendazole expressed as 
thiabendazole
no 0.1 Sum of thiabendazole and 5-OH-
thiabendazole, free and conjugated 
expressed as thiabendazole
0.02 0.02 2000 no The dietary burden for MRLs and 
STMRs were calculated as 303 and 
152 mg/kg for beef cattle and 163 
and 82 for dairy cattle.
1012030 Bovine liver Sum of thiabendazole and 5-OH-
thiabendazole expressed as 
thiabendazole
n.a. 0.3 Sum of thiabendazole and 5-OH-
thiabendazole, free and conjugated 
expressed as thiabendazole
0.2 0.21 2000 no The dietary burden for MRLs and 
STMRs were calculated as 303 and 
152 mg/kg for beef cattle and 163 
and 82 for dairy cattle.
1012040 Bovine kidney Sum of thiabendazole and 5-OH-
thiabendazole expressed as 
thiabendazole
n.a. 1 Sum of thiabendazole and 5-OH-
thiabendazole, free and conjugated 
expressed as thiabendazole
0.5 0.6 2000 no The dietary burden for MRLs and 
STMRs were calculated as 303 and 
152 mg/kg for beef cattle and 163 
and 82 for dairy cattle.
1016010 Poultry meat Sum of thiabendazole and 5-OH-
thiabendazole expressed as 
thiabendazole
no 0.05 Sum of thiabendazole and 5-OH-
thiabendazole, free and conjugated 
expressed as thiabendazole
n.c. n.c. 2000 no Significant intakes of thiabendazole 
by poultry are not expected. The 
supporting data are unclear
1020010 Cattle milk Sum of thiabendazole and 5-OH-
thiabendazole expressed as 
thiabendazole
no 0.2 Sum of thiabendazole and 5-OH-
thiabendazole, free and conjugated 
expressed as thiabendazole
0.12 0.15 2000 no The dietary burden for MRLs and 
STMRs were calculated as 303 and 
152 mg/kg for beef cattle and 163 
and 82 for dairy cattle.
1030000 Birds' eggs Sum of thiabendazole and 5-OH-
thiabendazole expressed as 
thiabendazole
n.a. 0.1 Sum of thiabendazole and 5-OH-
thiabendazole, free and conjugated 
expressed as thiabendazole
n.c. n.c. 2000 no Significant intakes of thiabendazole 
by poultry are not expected. The 
supporting data are unclear
(*) Indicates the lower limit of analytical quantification.
n.a.: not applicable
n.c.: not considered
n.k.: not known
Summary of CXLs for thiabendazole in livestock commodities
Commodity 
code
Commodity name
Values adopted by the CCPR
CXL (mg/kg)
Critical values of the JMPR evaluation Comment on the JMPR evaluationReview of the existing MRLs for thiabendazole 
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APPENDIX C.3 – VETERINARY MRLS 
 
 Review of the existing MRLs for thiabendazole 
 
EFSA Journal 2014;12(7):3750  50 
APPENDIX D – DECISION TREE FOR DERIVING MRL RECOMMENDATIONS  
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No
Yes
(I)
Maintain EU 
recommendation 
indicating that no 
CXL is available.
(II)
Maintain EU 
recommendation 
indicating CXL is 
not compatible.
(III)
Maintain EU 
recommendation 
indicating that 
CXL is covered.
(IV)
Maintain EU 
recommendation; 
higher CXL is not 
safe for consumer.
(V)
Maintain current 
CXL or EU 
recommendation?
(VI)
Maintain EU 
recommendation; 
higher CXL is not 
safe for consumer.
(VII)
CXL is 
recommended; EU 
recommendation 
is covered as well.
CXL available?
RD 
comparable?
CXL
supported by 
data?
Risk identified? Risk identified?
Codex median/
highest residues 
are included in the 
RA.
CXL is included in 
the RA.
Input values for 
the RA remain 
unchanged.
Input values for 
the RA remain 
unchanged.
No Yes
Yes
No
Yes
No
Yes No Yes No
Recommendations with consideration of the existing CXL
Comparison of the EU recommendation with the existing CXL
Consumer risk assessment with consideration of the existing CXL
Input values for 
the RA remain 
unchanged.
CXL higher?
Result EU 
assessment
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APPENDIX E – LIST OF METABOLITES AND RELATED STRUCTURAL FORMULA 
Common name  IUPAC name  Structural formula 
5-hydroxythiabendazole  2-(1,3-thiazol-4-yl)-1H-
benzimidazol-5-ol  N
H
N O H N
S
 
5-hydroxythiabendazole, 
O-sulfate conjugate 
2-(1,3-thiazol-4-yl)-1H-
benzimidazol-5-yl hydrogen sulfate  N
H
N N
S
S
O
O O
OH  
benzimidazole  benzimidazole 
N
H
N
 
2-acetylbenzimidazole  1-(1H-benzimidazol-2-yl)ethanone 
N
H
N
O
CH3 Review of the existing MRLs for thiabendazole 
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ABBREVIATIONS 
a.s.  active substance 
ADI  acceptable daily intake 
ARfD  acute reference dose 
bw  body weight 
CAC  Codex Alimentarius Commission 
CEN  European Committee for Standardization (Comité Européen de 
Normalisation) 
CF  conversion  factor  for  enforcement  residue  definition  to  risk  assessment 
residue definition 
CXL  codex maximum residue limit 
d  day 
DAR  Draft Assessment Report (prepared under Council Directive 91/414/EEC) 
DAT  days after treatment 
DM  dry matter 
DT90  period required for 90 percent dissipation (define method of estimation) 
EC  European Commission 
EFSA  European Food Safety Authority 
EMA  European Medicines Agency (former EMEA) 
eq  residue expressed as a.s. equivalent 
EU  European Union 
EURL  EU Reference Laboratories (former CRLs) 
FAO  Food and Agriculture Organization of the United Nations 
GAP  good agricultural practice 
ha  hectare 
HPLC  high performance liquid chromatography 
ILV  independent laboratory validation 
ISO  International Organisation for Standardization Review of the existing MRLs for thiabendazole 
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IUPAC  International Union of Pure and Applied Chemistry 
JMPR  Joint FAO/WHO Meeting on Pesticide Residues 
LC-MS/MS  liquid chromatography with tandem mass spectrometry 
LOQ  limit of quantification  
MRL  maximum residue limit 
MS  Member States 
OECD  Organisation for Economic Co-operation and Development 
PF  processing factor 
PRIMo  (EFSA) Pesticide Residues Intake Model 
PROFile  (EFSA) Pesticide Residues Overview File 
Rber  statistical calculation of the MRL by using a non-parametric method 
Rmax  statistical calculation of the MRL by using a parametric method 
RA  risk assessment 
RMS  rapporteur Member State 
RSD  relative standard deviation 
TRR  total radioactive residue 
WHO  World Health Organization 
 